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Published in October 2006, Smoking, Alcohol 
and Drug Use in Cork and Kerry 20041 reviews 
substance use in the former Southern Health 
Board area and compares findings with an earlier 
study conducted by the same author, Dr Timothy 
Jackson, in 1996.
The survey was divided into two parts. The first 
part was administered by an interviewer and 
covered a number of topics – general views 
on the respondent’s local area, knowledge of 
specific drugs, usage of tobacco and alcohol, 
attitudes about drugs and how they should be 
dealt with in the community, leisure activities and 
demographic information. The second part was 
a self-completion questionnaire which related to 
usage of drugs (including injecting drug use) and 
personal knowledge of people who had received 
or might need professional advice for alcohol- or 
drug-related problems. This article will focus on 
the findings in relation to alcohol consumption 
and drug usage. An article examining community 
perceptions of substance misuse issues will be 
included in the next issue of Drugnet Ireland. 
The methodology of the 2004 study was similar 
to that used in 1996. The survey was a multi-staged, quota-controlled household survey with 
random starting points. The target population was people living in the three main regions of the 
former Southern Heath Board (SHB): Cork City, Cork County and Kerry County. The main sample 
consisted of 1,512 respondents, aged between 15 and 44 years and divided equally between the 
three regions, with approximately 500 respondents from each region. 
In order to boost the number of those involved in substance use detected by the survey, a booster 
sample was also used. This targeted populations where there was considered to be greater risk of 
substance misuse. The booster sample consisted of approximately 900 respondents aged between 
15 and 24 years from the most deprived urban areas of each region. The only changes to the 
methodology between 1996 and 2004 were in relation to the booster sample. In order to increase 
statistical robustness it was increased from 600 to 900 and the areas of deprivation were based on 
the Small Area Health Research Unit index. The final analysis was based on 1,508 respondents from 
the main sample and 909 from the booster sample. 
The survey found that alcohol remained the dominant substance of misuse in terms of prevalence 
and problem use. Alcohol consumption was measured in units, where 1 unit is equal to a glass of 
wine, a measure of spirits or a half pint of beer, cider or alcoholic lemonade. Problem or dependent 
alcohol use was measured by responses to the four CAGE screening questions (see report for details). 
Eighty-one per cent of respondents were current drinkers, with the rate for women (79%) almost 
equal to that for men (82%). The rate of current drinking had increased by 3% since 1996. 
Twenty-six per cent of men and 17% of women drank in excess of guidelines. This figure had 
doubled for women since 1996. Twenty-two per cent of men and 11% of women were CAGE-
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positive, indicating problem or dependent use 
of alcohol. Men drank an average of 18 units 
and women an average of 9 units per week. This 
represented a 30% increase in women’s weekly 
consumption compared to 1996. Binge drinking 
was common for some respondents, with 50% 
of men and 25% of women reporting that they 
had drunk to excess three or more times in the 
previous month. 
The percentages of men in each of three 
categories of problem alcohol use had not 
changed significantly since 1996, with Category 
1 (excessive drinking) at 17%, Category 2 
(problem drinking) at 8% and Category 3 
(problem and dependent drinking) at 4%. 
However, women’s alcohol consumption had 
moved into more damaging categories. Those 
in Category 1 doubled to 13%, Category 2 
trebled to 3% and Category 3 increased to 1%. 
Of the respondents aged under 18 years, 41% 
(47% of boys and 32% of girls) were current 
drinkers (a drop of 3%). The proportion of this 
age group that reported having been drunk 
(87%) had increased by 15% since 1996. 
Drugs were categorised into cannabis, 
stimulants, opiates, hallucinogens, sedatives and 
solvents. Drug use was classified according to 
whether the substance was ever taken (lifetime 
use), taken in the last year (recent use) or taken 
in the last month (current use). The use of 
cannabis (in all forms) had doubled since 1996, 
with 32% reporting lifetime use, 14% reporting 
recent use and 7% reporting current use of 
the drug. The use of stimulants in general and 
ecstasy in particular had also doubled since the 
previous survey in terms of both lifetime use 
(stimulants 10% and ecstasy 7%) and recent use 
(stimulants 4% and ecstasy 2.5%). 
The numbers using cocaine and heroin 
remained low but there were marked increases 
in usage of these drugs since 1996. Lifetime 
use of cocaine increased from 1.1% to 6% 
and recent use increased from 0.4% to 2.5%. 
Lifetime use of crack increased from 0.3% to 
2%. The author points out that, while the actual 
prevalence levels are still low, ‘the increases 
show a serious trend’. Lifetime use of opiates 
doubled to 2% and recent use increased from 
0.3% to almost 1%. Lifetime use of heroin 
increased from 0.2% to 1.6% and recent use 
increased from 0.2% to 0.5%. 
When the three main regions were compared, 
Cork City showed the highest rates for all modes 
of drug use. Lifetime use was 41%, compared to 
30% elsewhere. Recent use was 18%, compared 
to 14% in Kerry County and 11% in Cork 
County. While there were significant increases 
in all categories of drug use in all three regions, 
this was particularly true in Cork County and 
Kerry County where rates of drug use doubled 
or tripled.
The author compared the study findings in 
relation to alcohol and drugs with a number of 
recent studies carried out to estimate substance 
use in the community. The findings regarding 
alcohol consumption were consistent with the 
NACD general population survey 2002/2003, 
the MWHB Secondary Schools Survey 2002, the 
European School Survey Project on Alcohol and 
Other Drugs 2003 and the Health Behaviour 
in Secondary School Children 2002 study. 
While the findings in relation to drug use were 
comparable to many school studies and other 
population lifestyle studies, overall drug use was 
much higher than the levels reported in the 
NACD general population survey 2002/2003. 
This may be due to methodological differences 
between the two studies. The NACD survey 
used direct interviewing throughout, but drug-
use data in this study were gathered using a 
confidential self-completion questionnaire. 
Research suggests that self-administered 
questionnaires lead to increased reporting 
of drug use, especially of stigmatising drugs, 
while direct interviewing may bias respondents 
towards what they perceive to be more socially 
acceptable answers (see report for references). 
The author stated that the increases in drug use 
found in this study were reflected in the data 
on problem drug use in the SHB reported to 
the National Drug Treatment Reporting System. 
(Sarah Fanagan)
1. Jackson TMR (2006) Smoking, Alcohol and 
Drug Use in Cork and Kerry 2004. Cork: 
Department of Public Health, HSE South.
Substance use in Cork and Kerry (continued)
Recent use 
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NACD general 
population survey 
2002/2003
%
Southern Health 
Board
(HSE South) 2004 
%
Southern Health 
Board
(HSE South) 1996 
%
Cannabis 5.0 14.0 6.6
Ecstasy 1.1 2.5 1.9
Cocaine 1.1 2.5 0.4
Crack 0.1 0.8 0.2
Heroin 0.1 0.5 0.2
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On 4 October 2006, the Health Service Executive 
(HSE) published an assessment of the need for drug 
and alcohol detoxification services in counties Cork 
and Kerry.1 Dr Mai Mannix, the report’s author, 
presented the main findings at the launch of the 
report in Cork. 
Dr Mannix reviewed data from a number of 
national databases to determine the numbers 
treated for drug and alcohol dependence and the 
medical consequences of drug and alcohol use. 
She interviewed 17 clinical decision makers from 
a range of professional backgrounds and one 
health service manager about their experiences 
of managing clients requiring detoxification 
services. Six clients were interviewed about their 
experiences of being assessed for and undergoing 
detoxification. She sent 512 questionnaires to 
doctors (GPs, hospital consultants and psychiatrists) 
and addiction counsellors in Cork and Kerry. Of 
these, 316 (62%) completed forms were returned. 
This questionnaire ascertained the respondents’ 
experiences of detoxification services and their 
recommendations for the future. 
Review of existing data sources
In relation to drug and alcohol use among the 
population living in Cork and Kerry, a report2 
published on the same day revealed that in 
2004 34% of the population aged between 15 
and 44 years had ever used a drug; cannabis 
was the most commonly used drug (32%); and 
opiates and solvents were used less frequently 
(2%). According to the 2003 SLAN survey,3 21% 
of the adult population of Cork and Kerry who 
drank on a weekly basis consumed more than 
the recommended weekly limit for alcohol. The 
number of cases who sought treatment for problem 
alcohol or drug use at the addiction services and 
were reported to the National Drug Treatment 
Recording System (NDTRS) increased steadily, from 
602 in 1999 to 1,859 in 2002; this was followed 
by a small decrease to 1,778 in 2003. Alcohol was 
the main problem substance in approximately 
two-thirds of the cases reported to the NDTRS. The 
National Psychiatric In-patient Reporting System 
recorded approximately 200 new cases treated 
for problem alcohol use in psychiatric units in the 
region each year between 2000 and 2002, while 
an annual average of 35 new cases were treated 
for drug dependence during the same period. The 
Central Treatment List reported that 38 persons 
with addresses in counties Cork or Kerry received 
methadone treatment during 2004; the small 
number of cases may have been due to a lack of 
treatment availability rather than to a low level of 
demand. 
The medical consequences of drug and alcohol 
use in Cork and Kerry were measured by reference 
to drug- and alcohol-related admissions to acute 
hospitals and death notifications. There was a 
notable increase in alcohol-related admissions to 
acute hospitals in the region, from 1,634 in 1999 
to 2,360 in 2001. The number of drug-related 
admissions to acute hospitals remained relatively 
stable at around 55 per year during the same 
period. There were 25 direct alcohol-related deaths 
and 55 direct drug-related deaths in the region 
in the period 2001 to 2003. Between 1995 and 
2001, the rate of deaths from chronic liver disease 
and cirrhosis of the liver (conditions associated 
with high levels of alcohol consumption) increased 
annually in Cork and remained relatively stable in 
Kerry. 
Detoxification requirements
Dr Mannix reported an increase in the number 
of addiction services providing treatment for 
problem drug and alcohol use, from three in 
1999 to 10 in 2003. She noted that, although a 
number of databases held data on alcohol and 
drug dependence, little information was available 
on the number of detoxifications provided to those 
treated. (Up until 2004, the type of substance was 
not specified in cases of detoxification reported 
to the NDTRS.) Using data from an area in the 
United Kingdom and a model developed by a 
Canadian researcher, Dr Mannix estimated that 
611 people living in Cork and Kerry would require 
detoxification from alcohol each year, 55 of them 
on an inpatient basis.
Drug and alcohol detoxification: a needs 
assessment for Cork and Kerry
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In-depth interviews
The key decision makers interviewed had 
experience in providing detoxification services in 
either a community or an inpatient setting. They 
reported that there was a need for a consultant 
psychiatrist specialising in addiction to lead the 
service. They said that a dedicated inpatient service 
was required in the region, and that general 
practitioners should be facilitated in providing 
additional outpatient detoxifications. They felt that 
services were required for people with drug and 
alcohol problems who were homeless, and that 
liaison workers were required to link detoxification 
with medication-free therapy and aftercare. The key 
decision makers were reluctant to develop a service 
for opiate users. 
The health service users interviewed reported that 
outpatient detoxification was available from general 
practitioners but that inpatient detoxification 
could be difficult to access. They agreed with 
the key decision makers that additional inpatient 
detoxification services were required. 
Postal survey
The survey of health service providers in the 
region revealed that all the psychiatrists and 
three-fifths of the general practitioners provided 
a detoxification service. The average number of 
detoxifications was 33 per year by psychiatrists and 
six per year by general practitioners. These were 
mainly detoxifications from alcohol, although 60% 
of psychiatrists and 30% of general practitioners 
had provided detoxifications from drugs (mainly 
hypnotic and sedative-type drugs) in the recent 
past. While almost three-quarters had referred 
clients to a service outside their own service, 65% 
reported difficulty in accessing other services, 
most notably the inpatient psychiatric service. Just 
71% had access to aftercare services for clients 
who had had a successful detoxification. With the 
exception of the psychiatrists, all service providers 
were dissatisfied with current service provision in 
the region. The majority recommended setting up 
a special detoxification unit, the employment of 
a consultant psychiatrist specialising in addiction 
to lead the service, and the expansion of general 
practitioners’ formal involvement in the service. 
The vast majority agreed that addiction counsellors 
should provide the link between detoxification 
and medication-free therapy or aftercare. These 
recommendations were in line with those of the key 
decision makers. 
Both the service providers and the key decision 
makers were reluctant to develop a service for 
opiate users in Cork and Kerry; this is possibly 
due to a lack of expertise in dealing with opiate-
dependent clients. (Jean Long) 
1. Mannix M (2006) Drug and alcohol detoxification 
services: a needs assessment for Cork and Kerry 
2005. Cork: Health Service Executive South. 
2. Jackson T (2006) Smoking, alcohol and drug use 
in Cork and Kerry 2004. Cork: Health Service 
Executive South. 
3. Centre for Health Promotion Studies, NUIG 
(2003) Survey of lifestyles, attitudes and nutrition 
(SLAN) and the Irish health behaviour in school-
aged children (HBSC) survey. Dublin: Department 
of Health and Children.
Drug and alcohol detoxification (continued)
The State Laboratory relocated from Abbotstown 
in County Dublin to Celbridge in County Kildare in 
May 2005. Its annual report for 2005 was released 
in October 2006.1 Under its customer charter, 
the State Laboratory is committed to providing a 
top-quality analytical and advisory service for its 
customers in an efficient and effective manner. 
Analysis is the core business of the laboratory.
The Human Toxicology Section of the Laboratory 
provides analytical support for coroners’ 
investigations. This involves analysing post-mortem 
samples from autopsiesto assist in establishing the 
cause of death. Information provided can indicate 
whether the deceased was taking medication at the 
time of death, if a drug overdose was taken, or if 
the deceased was under the influence of alcohol or 
drugs at the time of death.
This Human Toxicology Section also analyses 
biological samples pertaining to criminal 
investigations. Samples frequently require a 
variety of analyses in order to identify different 
drugs present. Specific analyses are available for 
illicit drugs, such as cocaine, ecstasy, opiates and 
cannabinoids. These drugs can be quantified and 
confirmed to a level that will satisfy the scrutiny of a 
court of law. A total of 2,311 samples were analysed 
during 2005. Illicit or abused drugs were present in 
81% of these samples, of which 55% showed the 
presence of an opiate. Cocaine and amphetamine, 
including ecstasy, were present in 16% of the 
samples and cannabinoids were present in 13% of 
the samples. (Ena Lynn)
The State Laboratory website is at www.statelab.ie
1. The State Laboratory (2006) Annual Report 2005. 
Dublin: Brunswick Press Ltd.
The State Laboratory Annual Report 2005
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The latest facts and figures on drug use across Europe, 
and by country, are contained in the 11th annual report 
of the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) launched on 24 November. The 
report includes information on the situation in Ireland 
provided by the Drug Misuse Research Division of the 
Health Research Board (HRB), which is the Irish national 
focal point for the EMCDDA. The report points to an 
increase in cocaine use, as evidenced by a rise in the 
numbers receiving treatment for cocaine use and in 
the number of prosecutions for possession of the drug. 
There is also evidence of changing patterns in drug use 
by females. 
Cocaine
Figures from the National Advisory Committee on 
Drugs (NACD) 2002/2003 general population survey 
show that 3% of the 4,918 respondents had used 
some form of cocaine at least once in their lives, with 
just over 1% having used cocaine in the last year 
(recent use). The proportions of the general population 
reporting cocaine use in 2002/2003 were similar to 
the European averages. The number of cases entering 
treatment and reporting cocaine as their main problem 
drug increased from 86 in 1998 to 352 in 2004. This 
figure represents 8% of the total number of cases 
entering treatment for drug use, which puts Ireland just 
below the European average of 12%. In 2005, cocaine-
related prosecutions accounted for just under 13% of 
the total, surpassing heroin-related prosecutions (11%) 
for the first time. The available data from An Garda 
Síochána and Customs suggest a significant increase in 
cocaine trafficking in Ireland in recent years. The Garda 
National Drugs Unit also reports a fall in the price of 
cocaine per gram. 
Drug supply
There has been a fall in the price of illicit drugs across 
Europe over the past five years. In Ireland, although 
there is evidence that the prices of ecstasy and cocaine 
have decreased over the last decade, the absence of 
a standardised method of monitoring current drug 
prices or trends over time makes it difficult to comment 
authoritatively in this area. The EMCDDA reports 
upward trends in heroin and cocaine seizures in most 
of Europe. Cannabis seizures account for the vast 
majority of all drugs seized in Ireland. The total quantity 
of heroin seized in Europe increased steadily since 
1999, and in 2004 reached a record level, up 10% 
on the previous year. Since 2001, the annual number 
of heroin seizures in Ireland has remained relatively 
stable at around 700 seizures. In 2005, 725 seizures 
were reported. The EMCDDA reports that there has 
been an increase over the last five years in the number 
and quantity of cocaine seizures and this is also true in 
Ireland. 
Injecting drug use and blood-borne viruses
Of the 3,403 cases entering treatment in 2004 who 
reported an opiate as one of their problem drugs, and 
who had their injecting status recorded, 74% had ever 
injected and 37% had injected in the month prior to 
treatment. According to data from prevalence studies, 
around one-tenth of injecting drug users in drug 
treatment are HIV positive. By European standards, 
Ireland is categorised as medium-prevalence in terms 
of HIV (with a HIV prevalence rate between 5% and 
10% among injecting drug users). Data from the 
Health Protection Surveillance Centre indicate a fall 
in the number of newly diagnosed HIV cases among 
injecting drug users between 1994 and 1998. Annual 
averages indicate a true increase in the number of 
HIV cases among injecting drug users since 1999. 
The results of prevalence studies indicate that around 
70% of injecting drug users attending drug treatment 
tested positive for antibodies to the hepatitis C virus. 
By European standards, Ireland is defined as high-
prevalence in terms of hepatitis C (with a hepatitis C 
prevalence rate over 60% among injecting drug users). 
Drug-related deaths
Direct-drug-related deaths are those occurring as a 
result of overdose. According to data from the General 
Mortality Register, there was a substantial increase in 
the number of drug-related deaths between 1995 and 
1999, followed by a considerable decline between 
2000 and 2002. This decline is in line with trends 
in drug-related deaths throughout Europe. In 2003, 
the number of drug-related deaths outside Dublin 
exceeded for the first time the number of drug-related 
deaths in Dublin. The data for outside Dublin follow 
trends in problem opiate use in that geographical area. 
Gender 
As in Europe, in terms of lifetime prevalence, almost 
twice as many men in Ireland (24%) as women 
(13%) reported ever using an illegal drug. However, 
the number of school-going girls who had ever used 
cannabis increased by 10%, from 29% in 1999 to 39% 
in 2003. The corresponding increase for boys was 3%. 
Of the 4,671 cases entering treatment in 2004, 1,212 
(26%) were female. The European average rate for 
female cases treated was 20%. Since 1999 a specialised 
service for pregnant drug users has been provided 
through a drug-liaison midwife at each of the three 
Dublin maternity hospitals. These midwives have formal 
links to community-based addiction centres. There was 
a steady increase in the number of drug-related deaths 
among women, from one in 1994 to 28 in 2000, and 
a levelling off in 2001 (at 25) and a small decrease 
in 2002 (to 21) and a small increase (to 28) in 2003. 
(Brian Galvin)
For a copy of the EMCDDA Annual Report 2006 and 
related press material, log on to the EMCDDA website 
at www.emcdda.europa.eu The DMRD media briefing 
on the report is on the HRB website at www.hrb.ie
The European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA) is the central 
reference point for drug information in the EU. 
Its role is to provide the EU and its member 
states with objective, reliable and comparable 
information on drugs and drug addiction. The 
main information sources for the EMCDDA 
are the national focal points set up in each EU 
member state and in Norway. 
2006 European report on the drugs 
problem The number of 
cases entering 
treatment and 
reporting cocaine 
as their main 
problem drug 
increased from  
86 in 1998 to 352 
in 2004.
around 70% of 
injecting drug 
users attending 
drug treatment 
tested positive for 
antibodies to the 
hepatitis C virus

drugnet 
IRelaND
drugnet 
IRelaND

Professor Jane Fountain of the University of Central 
Lancashire assessed the nature and extent of illicit 
drug use in the Traveller community in Ireland. The 
report was commissioned by the National Advisory 
Committee on Drugs and launched in October 
2006.1
The report provides data on drug use, the patterns 
of drug use, problematic drug use, drug-related risk 
behaviours, the effect of drug use on the Traveller 
community and gaps in service provision. The data-
collection techniques included a comprehensive 
review of the literature, interviews with 34 agency 
staff, focus groups with 122 Travellers and one-
to-one interviews with 15 Travellers who were 
using or had used drugs. The data were analysed 
thematically using a grounded theory approach. 
According to this report, it is estimated that there 
are 30,000 Travellers in Ireland and a further 
15,000 in the UK. Many of those living in the UK 
travel between there and Ireland on a regular basis. 
Travellers have their own language and distinct 
culture, with a unique value system and specific 
customs and traditions. Successive governments 
have introduced legislation and policies to protect 
the rights of Travellers, but many of these are not 
implemented in a systematic way throughout 
the country. Travellers continue to experience 
discrimination and marginalisation. The author 
reported that they are socially excluded and do 
not have equal access to education, health care, 
employment or accommodation. Traveller children 
are six times more likely to be cared for by local 
authorities than children in the general population. 
The Traveller community, like other socially 
excluded populations, is vulnerable to problematic 
drug use.
As the author notes, the 2002/2003 national 
survey of drug use in the general population2 did 
not record ethnicity, and nor does the National 
Drug Treatment Reporting System (NDTRS). 
Consequently, there are no reliable estimates of 
either drug use or treated problem drug use among 
the Traveller population. Following requests from 
some of the addiction service managers, the NDTRS 
will introduce a system to identify the number 
of Irish Travellers seeking treatment from 2007 
onwards. 
Qualitative research indicates that cannabis, 
sedatives, tranquillisers and antidepressants are 
the drugs most commonly used in the Traveller 
community. These are followed by cocaine and, 
to a lesser extent, ecstasy. These findings mirror 
the pattern of drug use in the general population. 
In addition, the Traveller population reported 
occasional use of amphetamines. The less common 
substances used by Travellers were heroin, crack 
cocaine, LSD and solvents, again mirroring the 
pattern in the general population. Injecting drug 
use among the Traveller community was not 
commonly reported. As in the general population 
survey, more male than female Travellers used 
drugs, and those in the age range between 
adolescence and early thirties were more likely to 
be users. The impact of drug use on Traveller users 
included poor personal health, involvement in 
criminal activity, exclusion from the family and the 
broader community, and stigmatisation. Members 
of the drug user’s family were likely to suffer from 
stress. 
The Travellers interviewed described some of 
the ways their community dealt with drug use, 
including home detoxification, avoiding drug-using 
friends, promising a priest not to use any more 
drugs and seeking treatment. The author reported 
that formal treatment was rarely sought. There was 
no consensus on how to deal with drug dealing in 
the Traveller community and it was reported that 
the gardaí were reluctant to tackle the issue. There 
was evidence throughout the research findings that 
there was a lack of knowledge about drugs and 
drug use among Travellers. There are a number 
of barriers to accessing drug treatment services: 
lack of awareness of such services, lack of formal 
education, stigma and embarrassment, lack of 
cultural competence among service providers and 
perceptions of racism within services. 
The key recommendations of the report were:
Develop procedures on ethnic monitoring.
Carry out equality proofing of policies and 
procedures in social, health and drug-related 
■
■
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services.
Increase awareness of drugs and drug use 
among Travellers using appropriate methods.
Adapt the existing drug services so that 
Travellers can access them.
Implement a process to engage the Traveller 
community in addressing drug use. 
Conduct further research. 
(Jean Long)
■
■
■
■
1. Fountain J (2006) An overview of the nature and 
extent of illicit drug use amongst the Traveller 
Community: an exploratory study. Dublin: 
Stationery Office. 
2. National Advisory Committee on Drugs and 
Drug and Alcohol Information and Research Unit 
(2005) Drug use in Ireland and Northern Ireland. 
2002/2003 drug prevalence survey. Health Board 
(Ireland and Health and Social Services Board 
(Northern Ireland) results (revised). Bulletin 2. 
Dublin: NACD.
This seminar, hosted by Merchants Quay Ireland and 
Pavee Point, explored issues identified in two recent 
studies dealing with drug use among members of 
new communities in Ireland and among Travellers.1,2 
The authors of the two reports, Caroline Corr of 
the Combat Poverty Agency and Professor Jane 
Fountain, University of Central Lancashire, presented 
their findings. Mr Manjit Singh Johal, Service User 
Involvement & Advocacy Officer, Derbyshire Drug 
and Alcohol Addiction Team, and Mr Yaser Mir of 
the Centre for Ethnicity and Health, University of 
Central Lancashire, also spoke to the seminar. The 
seminar was held in Dublin on 2 November and 
was attended by delegates from several statutory, 
community and voluntary organisations and NGOs. 
(Brian Galvin)
1. Corr C (2004) Drug use amongst new communities 
in Ireland: an exploratory study. Dublin: National 
Advisory Committee on Drugs.
2. Fountain J (2006) An overview of the nature and 
extent of illicit drug use amongst the Traveller 
community: an exploratory study. Dublin: 
Stationery Office
Drugs and Diversity seminar
Yaser Mir, Centre for Ethnicity and Health, 
University of Central Lancashire
Emma Kennedy, TSDI Pavee Point; Philip Watt, Director NCCRI; Lambert Oliput, Chair of NeCoDrA
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Although problems associated with open drug 
scenes are not new, we have witnessed a greater 
level of public concern, debate and analysis of 
such issues at the national and international levels 
in recent times.1,2 A Council of Europe report3 on 
the issue provides an overview of the hearings of 
the Pompidou Group Criminal Justice Platform 
between 2004 and 2006. During this period, the 
Platform convened five meetings on the topic and 
heard presentations from 30 cities throughout the 
European Union and beyond.4
A central concern is the idea of the public being 
confronted in their day-to-day lives with open 
drug dealing and drug use. The genesis and scale 
of the problems experienced vary from place to 
place. The size of the drug scene can also vary 
greatly, from small isolated pockets of individuals 
to scenes with thousands of participants. This can 
also be affected by the duration of the drug scene 
and the way in which such scenes can exercise a 
‘pull-effect’, attracting drug users or ‘drug tourists’ 
from other cities or countries. Drug scenes can 
also attract people who are not primarily looking 
for drugs but are engaging in other activities that 
may be associated with the drug scene, such as 
prostitution. Included among the problems and 
activities associated with open drug scenes are the 
following: 
 Drug-related mortality; Involvement of 
organised crime groups; Violence and gang turf 
wars; Drug-related petty crime in surrounding 
vicinity; Prostitution; Visible drug intoxication; 
Visible drug use and injecting; The discarding 
of needles and other drug paraphernalia; Drug 
tourism; Emergence of houses where drugs are 
sold and/or used – ‘Crack’ houses; Development 
of a poly-drug market; Open drug scenes 
can make it difficult for drug users to address 
their addiction due to visible temptation; 
Creation of ‘no-go’ areas for local residents 
due to fear; Contribution to stigmatisation of 
local community; Street homelessness; Noise 
pollution; Attraction of young people to the 
drug scene; Interference with traffic on roads 
adjacent to the drug scene.
Most countries have acknowledged that the 
complexity of the various problems which arise 
in this context require an equally sophisticated 
response. Motivated by a concern to balance the 
general welfare of the broader community with 
the safety and health of drug users, contemporary 
approaches seek new and innovative ways of 
dealing with these old problems. Strategic thinking, 
in-depth problem analysis, long-term planning and 
partnership between agencies and stakeholders 
are characteristic of this new development. This 
represents a movement away from reactions based 
primarily on repression and strict law enforcement. 
Such partnership approaches, often involving 
collaboration between law enforcement, social and 
health services and other stakeholders including 
local communities, have faced their own obstacles 
and challenges. Nevertheless, there is a growing 
consensus that partnership working offers the most 
sustainable method of responding to many drug 
problems.
Many of the practical examples of partnership 
presented to the Criminal Justice Platform combine 
elements both of tolerance and repression and 
therefore they do not lend themselves to typical 
categorisation as either repressive or liberal. This 
can be as a result of the need to find, within a 
particular local context, a compromise between 
pressure groups. At given times a repressive 
approach can dominate the response, for example, 
where open drug scenes expand to unmanageable 
proportions or when related crime and nuisance 
levels attract media attention and/or lead to 
demands from local residents, business interest 
groups or politicians for swift action. Opposition 
of this nature can lead to the mobilisation of local 
residents’ groups or intensive policing aimed at 
removing the open drug scene. However, the 
experience in many countries is that such action, 
while understandable from the perspective of 
the local pressure group perhaps, is a short-term 
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The European Commission has issued a 
Communication1 outlining a comprehensive 
strategy to support member states in combating 
the harmful effects of alcohol use in the European 
Union (EU), especially among young people. In 
preparing the Communication, the Commission 
asked RAND Europe to conduct an assessment 
of the economic impacts of EU alcohol policies. 
The resulting document, An ex ante assessment of 
the economic impacts of EU alcohol policies,2 was 
published in August 2006. The main objectives of 
this report were: 
to assess the current macroeconomic 
impacts of alcohol use and the likely future 
macroeconomic impacts of the policy; and
to assess the current economic contribution of 
the alcohol industry and the likely impacts of 
the proposed policy on the industry.
Alcohol consumption is associated with many 
harmful health, social and economic consequences 
throughout the EU. Fifteen per cent of Europeans 
(58 million adults) consume harmful or hazardous 
levels of alcohol. Alcohol is responsible for 11% of 
■
■
EU considers economic impact of alcohol 
policies
response which generally only serves to displace 
the drug scene to a different residential location, 
or to a public place such as a train station. 
Furthermore, the drug scene is often driven 
underground and, while the nuisance concerns 
of the local public may have been addressed, the 
health predicament of drug users can deteriorate 
as they become invisible and inaccessible to harm 
reduction measures, drug treatment and social 
and health services. In some experiences, the 
repression and dispersal of ‘open drug scenes’ 
has been associated with increases in drug-
related deaths and other drug-related harms. 
Also, the removal of open drug markets through 
intensive law enforcement can lead to adaptation 
by drug dealers and the development of more 
closed markets, based in local houses, facilitated 
by mobile phones for example and increasingly 
impenetrable to police or other services.
Partnership working has raised a number of 
challenges for stakeholders. Policing authorities 
have had to acknowledge that their response 
must move beyond strict law enforcement and 
towards more problem-oriented policing. On the 
other hand, social care personnel are challenged 
to accept that there is a role for law enforcement, 
particularly in terms of addressing the concerns 
of the wider public with regard to drug-related 
nuisance. For local residents, accepting the 
establishment of drug treatment facilities close to 
their homes has been a contentious issue.
Addressing and overcoming community fears 
or tackling traditional professional and cultural 
assumptions by agency personnel form an 
important component of the overall challenge 
of partnership working. The ability to overcome 
such challenges is dependent upon a range of 
factors. Among the most important of these 
is the infrastructure of partnership; that is the 
coordinating, decision-making and communication 
systems agreed by the various stakeholders 
to facilitate their collaboration. Based on the 
experiences presented to the Criminal Justice 
Platform, and to inform future partnership 
initiatives, the report concludes by identifying 
a series of common principles of partnership 
and a number of good practice guidelines. The 
guidelines cover the following areas: Problem 
analysis and planning; Partnership structure and 
coordination; Communications; Trust and conflict; 
Training and education; Recruitment and status of 
partnership. 
In September 2006, a conference on drugs was 
organised as part of Finland’s presidency of the 
European Union. The focus of the conference was 
the issue of inter-agency cooperation in response 
to drug-related issues.5 One of the outcomes of 
the conference was the agreement to create an 
international network of partnerships. The Council 
of Europe’s Pompidou Group is to shortly take 
on the task of creating and co-ordinating such a 
network. (Johnny Connolly)
A copy of the report can be obtained from the 
National Documentation Centre at  
http://www.ndc.hrb.ie/attached/ 
2993-RespondingToOpenDrugScenes.pdf
1. EMCDDA (2005) Drug-related public nuisance 
– trends in policy and preventive measures. 
In Annual Report 2005: Selected issues. 
Luxembourg: Office for Official Publications of 
the European Communities.
2. International Narcotics Control Board (INCB) 
(2004) Report 2003. New York: United Nations 
Publications.
3. Connolly J (2006) Responding to open drug 
scenes and drug-related crime and public nuisance 
– towards a partnership approach. Strasbourg: 
Pompidou Group, Council of Europe.
4. Copies of the individual presentations will be 
published by the Council of Europe in due 
course.
5. The report of the conference can be found at 
http://www.stm.fi/Resource.phx/eng/subjt/
inter/eu2006/drugs/drugs1.htx
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premature death and disability among males. It is 
now the third leading risk factor for the EU disease 
burden, after tobacco and obesity. Drunkenness 
and binge drinking among young people are 
becoming more widespread. Among 15–16-year-
olds, binge drinking occurs frequently and 25% of 
all alcohol-attributable deaths in the EU occur in 
the 15–29-year age group. It is estimated that the 
tangible cost of alcohol-related harm in the EU in 
2003 was €125 billion, accounted for by health 
care costs, crime, traffic accidents, lost productivity 
and premature mortality. This figure does not 
include intangible costs, which incorporate the 
value people place on pain, suffering and loss 
of life that occur due to the criminal, social and 
health harms caused by alcohol. These costs are 
estimated to be in excess of €270 billion. 
Although the cost of alcohol to European society 
is substantial, the economic role of the industry 
in many European countries is considerable. 
Alcohol accounts for 13.9% of total expenditure 
on foodstuffs and 1.6% of overall consumer 
expenditure. It is estimated that alcohol 
contributes approximately €45 billion and 1.2 
million jobs (not including those in the catering 
industry) to the economy of the EU. In Ireland, 
alcohol comprises 1.3% of the total value of 
exports and generated a positive trade balance of 
€513 million in 2004.
It is recognised that the effectiveness of harm-
reduction policy depends on the prevalence of 
harmful alcohol use. In populations with a high 
prevalence of heavy drinking, taxation is the 
most cost-effective approach, whereas targeted 
strategies, such as brief interventions at primary 
care level, random breath testing, or advertising 
bans, are most cost-effective in populations with 
a low prevalence. Increases in excise duties are 
associated with only modest decreases in overall 
alcohol consumption but there is evidence to 
suggest that they are very effective in the case of 
heavy drinkers and young drinkers.
The report outlined four options for future alcohol 
policy identified by the Commission (p. xiv):
1. No change: Policy decisions and initiatives 
will be left largely to Member States and 
stakeholders, while the EU continues to 
finance projects and networks, support 
research, facilitate exchange of best practice, 
and collect and disseminate information on 
alcohol consumption and harm, but does not 
coordinate activities across policy domains.
2. Coordination of activities at EU level: this 
is similar to option 1, but the EU would 
encourage stakeholders throughout the EU 
region to undertake similar activities (e.g. 
self-regulation, common codes of conduct on 
commercial communication, exchange of best 
practice on interventions) and to hold Member 
States to their Treaty obligations.
3. A comprehensive strategy: Application of a 
wide variety of policy instruments (legislation, 
self-regulation, information and education 
campaigns, exchange of best practice, 
stakeholder involvement) across all relevant 
policy domains (internal market, taxation, 
transport, education, research and consumer 
policy). The strategy would focus on drink-
driving, co-ordinated campaigns, protection 
of third parties, commercial communication, 
consumer information and availability and 
prices.
4. Purely regulatory: Focus on the use of the 
policy instrument of regulation to achieve a 
decline in the harmful effects of alcohol use.
Following evaluation of each option, the authors 
suggested that options one and two would 
not result in a decline in the harmful effects 
of alcohol use. They found that option three 
was potentially the most efficient and effective 
approach as it combined policies intended to 
lower alcohol use with activities targeting the 
behavioural foundations of harmful drinking. 
Option four would lower alcohol use through 
stricter regulation and enforcement, and 
presented a number of advantages with respect 
to drink-driving, health care and public revenues. 
This option was the one most likely to harm the 
alcohol industry and its supplying industries. Its 
main disadvantage was that, without a supporting 
information and education campaign, changes 
in use might not become engrained in consumer 
behaviour. 
The main conclusion of this report was that a 
European alcohol policy based on option three 
represented the preferred choice. By combining 
a wide variety of policy instruments, this 
option targeted the behavioural foundations 
of harmful drinking as well as lowering alcohol 
use by reinforcing cost-effective regulation and 
enforcement measures. (Deirdre Mongan)
 1. Directorate-General Health and Consumer 
Protection (2006) An EU strategy to support 
member states in reducing alcohol related harm. 
COM/2006/0625 final. Brussels: Commission of 
the European Communities.
2. Horlings E and Scoggins A (2006) An ex ante 
assessment of the economic impacts of EU alcohol 
policies. A technical report for the European 
Commission. Cambridge, UK: RAND Europe.
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While the National Drugs Strategy focuses 
entirely on illicit drugs, calling simply for 
‘complementarity’ between illicit drugs and 
alcohol policies, the majority of the RDTF strategies 
address both alcohol and drugs misuse. A variety 
of reasons is given – because alcohol is the biggest 
problem drug; because alcohol is a bigger problem 
than drugs, and given the ‘deregulation’ of the 
sale of alcohol, treatment service provision needs 
to be funded as a priority; because polydrug use, 
including alcohol misuse, is prominent among 
young people using drugs and the alcohol and 
drug cultures are intertwined and need to be 
addressed as part of an inclusive approach. One 
plan calls for a co-ordinated approach between 
issues to deal with illicit drug abuse and alcohol 
abuse but only among teenagers, on the basis that 
alcohol is not an illicit drug for adults. Two plans, 
neither of which address the problem of alcohol 
misuse at all, call for the omission of alcohol 
from the terms of reference for the RDTFs to be 
reconsidered by the government.
Alcohol-related supply reduction or control 
measures identified in the RDTF plans include 
more regulation of off-licences and supermarkets, 
introduction of a responsible sale of alcohol 
programme, opposition to ‘happy hours’ 
and alcohol promoting events, and rigorous 
enforcement of the law in relation to alcohol. 
Prevention measures include health promotion 
campaigns to ensure public awareness of alcohol 
and related issues, and early health promotion 
interventions to curb the sale of alcohol to under-
age young people. Treatment measures include the 
use of validated screening tools, brief interventions 
for people with problem alcohol use or alcohol 
dependence, counselling, and community-based 
alcohol detoxification services. 
The urban versus rural location of drug misusers 
presents a number of challenges not addressed 
by the National Drugs Strategy but, hardly 
surprisingly, the matter is raised by a number of 
RDTFs. With regard to the supply and control 
of drug markets, concerns are voiced about the 
nature of links and movements between urban 
areas and their rural hinterlands. In relation to 
drug-related treatment services, it is pointed out 
that urban areas may have a critical mass of service 
users concentrated in the one locality, resulting 
in economies of scale for service provision and 
ease of access for users; in rural areas, however, 
potential service users may be widely scattered 
in small villages or remote areas, without easy 
access to transport. This poses logistical and social 
challenges in terms of providing services that 
are both accessible to users, (either by offering 
transport to larger centres or through providing 
services locally), and also discrete, (in order to 
minimise the risk of stigma attaching to those seen 
attending the service). 
In line with the National Drugs Strategy, the 
RDTFs acknowledge social inclusion as the 
policy framework within which their strategies 
and actions are set. The Western RDTF strategy 
document devotes a whole chapter to social 
inclusion. It describes the nature of the linkage 
between drugs and social exclusion – ‘Poverty 
RDTF strategies push out the boundaries
By mid-2005, all 10 regional drugs task forces (RDTFs) had submitted their first strategic and/or action plans 
to the National Drugs Strategy Team for approval (see Table 1).1 Aligned with, and intended to contribute 
to the achievement of the overall aims of the National Drugs Strategy, and the objectives and actions under 
the four pillars, these regional strategies also highlight additional policy concerns, a selection of which is 
noted below.
Table 1 Regional drugs task forces and catchment areas
Regional drugs task force Catchment area
East Coast South Dublin City and County excluding seven LDTF areas,  
East Wicklow
Midland Counties Laois, Longford, Offaly, Westmeath
Mid-Western Counties Clare, Limerick, North Tipperary
North Dublin City and County North Dublin City and County excluding five LDTF areas
North East Counties Cavan, Louth, Meath, Monaghan
North West Counties Donegal, Leitrim, Sligo and north-west Cavan
Southern Counties Cork, Kerry
South East Counties Carlow, Kilkenny, South Tipperary, Waterford, Wexford
South West South and West Dublin, West Wicklow and County Kildare
Western Counties Galway, Mayo, Roscommon
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and deprivation are more likely to encourage 
than discourage drug use, and substance misuse 
can be both cause and effect of social exclusion’2 
– and discusses the needs of specific socially-
excluded groups, including those living in remote 
rural areas or in socially disadvantaged areas, the 
homeless, Travellers, and prisoners. It also identifies 
several tailored service developments to weaken 
the link between the socially excluded and illicit 
drugs, including assertive outreach initiatives, 
decentralised mechanisms that reach to the heart 
of rural areas, and focusing on outcomes for 
socially excluded target groups and working to 
solve the full range of their problems, including 
substance misuse, in an integrated fashion.
Recent commentators in the UK have 
problematised the concept of social exclusion. 
It has been found difficult to test the concept 
empirically, i.e. to find evidence of social exclusion 
as distinct from social or economic deprivation, 
and it has been argued that the concept has 
served to mask the inequalities and conflicts 
of interest said to be inherent in market-based 
societies and to affect a much larger cross-section 
than those categorised as ‘socially excluded’.3 The 
relationship between social exclusion policy and 
the drugs issue has also been questioned. It has 
been suggested that filtering drug policies through 
a social exclusion policy framework may not 
directly benefit drug misusers: ‘allowing a social 
exclusion agenda to determine our drug policies 
will skew services heavily towards those that 
attempt to prevent crime, reassure the frightened 
and promote employment – that is, away from 
those that prioritize the complex needs of people 
who are actually addicted.’4
As an alternative to social inclusion, the Southern 
RDTF has based its strategic plan within an 
equality framework. Its assessment of the drugs 
and alcohol situation in the southern region is 
organised around consideration of seven of the 
nine grounds specified in Ireland’s Equal Status 
Act 2000 (gender, sexual orientation, family 
status, age, disability, race and membership of 
the Travelling community), two of the proposed 
additional grounds (criminal convictions and 
socio-economic status), and two other variables 
(homelessness, and literacy levels, which may have 
an influence on the effectiveness of prevention 
strategies). The choice of an equality framework 
is justified thus: ‘The challenge for the Southern 
Regional Drugs Task Force in setting forth its four-
year strategy is to ensure that the agreed policy 
and its implementation will meet people’s needs 
and positively impact on their lives. To achieve that 
requires the rethinking of established norms. … 
More and more it has come to be accepted that 
the ‘one size fits all’ policy framework does not 
work and in its place what is required is a more 
targeted, focused approach.’5 
While targeting is necessary to meet needs specific 
to particular groups experiencing inequality, 
Niall Crowley, CEO of the Equality Authority, has 
recently argued that that it must be matched 
by mainstreaming, which seeks to promote 
equality through all key policies, programmes 
and practices: ‘A dual strategy means that some 
targeted initiatives will be taken to support 
the capacity of mainstream institutions and 
organisations to take account of diversity and to 
promote equality. It means that mainstreaming will 
stimulate decision makers to put in place targeted 
initiatives where inequalities are identified that will 
not be addressed by general policies, programmes 
or practices.’6 (Brigid Pike)
1. Regional drugs task forces (RDTFs) were 
established in 2003, in line with Actions 
92–97 of the National Drugs Strategy 2001–
2008. Their terms of reference include the 
development of a ‘co-ordinated and integrated 
response to tackling the drugs problem in their 
region’. To date, the strategic plans of five 
RDTFs have been described Drugnet Ireland: 
North East (Siobhán Reynolds, Issue 15, p.1), 
Western (Sarah Fanagan, Issue 18, p.19), 
Southern (Siobhán Reynolds, Issue 19, p.12), 
North West (Sarah Fanagan, Issue 19, p.21) and 
Midland (Sinéad Foran, Issue 20, p.13).
2. Western Drugs Task Force (2006) Shared 
solutions: first strategic plan of the Western 
Regional Drugs Task Force. Castlebar: WRDTF, 
p.37.
3. See Welshman J (2006) Underclass: A history of 
the excluded 1880–2000. London: Hambledom 
Continuum, for an account.
4. Neale J (2006) Social inclusion and drug policy. 
In Hughes R, Lart R and Higate P (eds) Drugs: 
policy and politics. Maidenhead, Berks: Open 
University Press, p.14. 
5. Southern Regional Drugs Task Force (2005) 
Strategic plan 2005–2008 and action plan 2005–
2007. Cork: SRDTF, pp.8–9. 
6. Crowley N (2006) An ambition for equality. 
Dublin: Irish Academic Press, p.120.
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The Midland Regional Drugs Task Force (MRDTF), 
one of 10 regional drugs task forces (RDTFs), was 
established in 2003 with the assistance of the 
National Drugs Strategy Team (NDST). It covers 
counties Laois, Offaly, Longford and Westmeath. 
In November 2005 the MRDTF published its first 
action plan1 to tackle drug misuse in the region.
The MRDTF action plan is the result of an extensive 
consultation process carried out in the region in 
2005. This process allowed relevant statutory, 
voluntary and community groups to contribute to 
the development of the plan. Key issues relating to 
drug misuse in the region were identified, along 
with suggestions for addressing these issues; all 
contributions were taken into account by the 
MRDTF in the development of the action plan.
The plan sets out actions relating to the four pillars 
of the National Drugs Strategy. It includes a further 
strand concerned with structure, governance and 
ways of working. Alcohol use is not included in 
this plan except where it concerns under-18s, on 
the basis that alcohol is not an illicit drug. The 
following key actions are given high and urgent 
priority:
Education/Prevention
Establish an inter-agency team in the MRDTF 
to develop and deliver accredited training 
programmes on substance misuse to local 
community development groups.
Develop and disseminate a range of materials 
appropriate to relevant audiences, and train 
individuals to deliver these materials, with 
particular emphasis on out-of-school settings, 
non-formal education and parent-support 
settings.
Design, develop and deliver a drugs education 
programme to GPs and pharmacies. 
Encourage and support the implementation 
of the Youth Work Act 2001 by assisting in 
the development of youth action plans and 
ensuring that substance misuse prevention is a 
key component of the plans. 
Ensure that all schools and other educational 
and training establishments implement a 
comprehensive substance misuse prevention 
programme and appoint a worker to support 
these programmes.
Treatment/Rehabilitation
Provide and support a residential treatment/
rehabilitation programme in the region. 
Provide a range of drop-in centres and facilities 
throughout the region for those affected by 
substance misuse. Initially this will involve 
■
■
■
■
■
■
■
four pilot projects, with a long- term goal to 
expand to twelve.
Establish a support service for under-18s that is 
in line with the under-18s protocol. 
Ensure that drug users have access to 
detoxification programmes within the region. 
Establish a users group to provide feedback in 
relation to services in the region and to act as a 
support group for users.
Supply reduction
Extend the community policing fora into the 
MRDTF area.
Promote and support the establishment of 
estate-management programmes in high-
priority estates in all four counties in the 
region. 
Explore the potential use of non-custodial 
interventions in tackling drug misuse. 
Research
Establish a programme for collecting local 
information that is up to date, using existing 
research mechanisms and a template designed 
for collecting data at a local level. 
Engage with young people in the region to 
ascertain their views.
Structure, governance and ways of working
Select members of the MRDTF from 
among voluntary, community and public 
representatives, and senior decision makers in 
relevant agencies
Appoint an MRDTF co-ordinator, a 
development worker and an administrator.
Design and deliver an induction programme 
for new staff members and organise relevant 
training programmes for all members of the 
MRDTF.
Initiate and support the establishment of 
community drug action groups in each major 
town of the region.
Explore a co-ordinated approach between 
initiatives to deal with illicit drug use and 
alcohol abuse among teenagers and develop 
appropriate actions for reducing alcohol 
consumption. 
(Sinéad Foran)
1. Midland Regional Drugs Task Force (2006) 
Action Plan 2006–2008. Tullamore: Midland 
Regional Drugs Task Force.
■
■
■
■
■
■
■
■
■
■
■
■
■
Midland Regional Drugs Task Force: 
Action Plan 2006–2008
On 24 November 2006 the Minister for Labour 
Affairs, Tony Killeen TD, launched the Business 
in the Community Ireland Ready for Work (RFW) 
programme review 2002–2006.1 The overall aim 
of this programme is to enable homeless people to 
break the cycle of no home – no job – no home. 
The RFW programme provides work experience 
opportunities to unemployed homeless adults. It 
involves two days’ pre-employment training, two 
weeks’ unpaid work experience with in-house 
support, and follow-up support from training and 
employment officers and job coaches. Programmes 
are run three times a year and serve as a first step 
for candidates who have been through the homeless 
services, and in some cases the addiction and 
related support services, and are re-entering the 
world of work. 
The review includes a number of candidates’ stories 
highlighting the personal and social progress made 
in the course of their involvement with the RFW 
programme. Some describe the positive impact of 
treatment for alcohol and drug misuse in assisting 
the candidates to move beyond their experience 
of homelessness towards engagement with the 
programme. 
The review also includes information on outcomes 
of the 12 programmes run in the years 2002 to 
2006. It reports that 118 candidates commenced 
the programme, of whom 53 have commenced 
work; 44 have accessed further training and 
education; and 19 are now living independently. 
The RFW programme is innovative in a number of 
ways.
1. There is a strong partnership approach between 
the candidates, the business sector and homeless 
service providers such as the homeless agency. 
Some 20 corporate supporters offer funding, 
facilitators, job coaches or work experience 
placements. A minimum of 20 homeless service 
providers are engaged with and support RFW. 
2. The programme has input from a steering 
group of members of the business community. 
The remit of the steering group is to increase 
awareness of the RFW programme among 
employers, to increase the pool of companies 
involved, to communicate issues faced by 
candidates to prospective RFW companies, and 
to ensure productive two-week placements by 
matching skills to jobs. 
3. The programme offers job coaching by 
matching a volunteer from the business sector to 
a candidate who has completed a programme, 
in a six-month coaching relationship.
A study by Lawless2 highlighted the lack of 
progression routes to work placement for 
participants in drug treatment and engaged in 
vocational training in Dublin North East. The 
National Economic and Social Forum3 recently 
highlighted the issue of labour market vulnerability 
among marginalised groups and called for a 
targeted response to the issue. Platt4 and Kemp 
et al.5 highlighted the benefits of supported work 
interventions for groups such as clients in drug 
treatment and ex-prisoners with addiction issues. 
For example, knowing that work experience was 
a feasible option was a key motivating factor in 
completing training. Also, the high levels of support 
given to participants were a major factor in enabling 
the completion of programmes; this was a feature of 
the RFW programme. 
The business sector also benefits from involvement 
in the RFW programme. According to the 
co-ordinator of the programme, Rosemary Carvill, 
 the greatest learning for many of those in the 
corporate sector has been the realisation that 
people ‘out of home and out of work’ are not 
so different from themselves. They also discover 
how little it takes to help someone to regain 
control of their life. 
The RFW programme is an example that can be 
taken and developed by drug treatment agencies 
in partnership with employers in targeting the 
vocational and employment needs of individuals 
who are seeking to move beyond the drug 
treatment system. The merits of this programme 
have been extolled in a recent editorial in the Irish 
Times (30 October 2006):
 The Ready for Work scheme, designed to 
provide jobs for the homeless, is a particularly 
useful exercise in that it reaches out to the 
dispossessed and allows them a chance to start 
afresh. Homeless people are at a particular 
disadvantage when they look for work because 
they have to use a hostel or temporary 
accommodation as their address. As a result, 
they are invariably not called for interview. In 
order to circumvent that problem, a range of 
major companies have been encouraged to 
commit, in advance, to the employment of 
homeless persons. 
(Martin Keane)
1. Business in the Community Ireland (2006) Ready 
for Work review 2002–2006. Dublin: Business in 
the Community Ireland.
2. Lawless K (2006) Listening and learning: 
evaluation of Special Community Employment 
programmes in Dublin North East. Dublin: Dublin 
North East Drugs Task Force. 
3. National Economic and Social Forum (2006) 
Creating a more inclusive labour market. Report 
33. Dublin: National Economic and Social 
Development Office.
4. Platt JJ (1995) Vocational rehabilitation of drug 
abusers. Psychological Bulletin, 117(3): 416–433.
5. Kemp K, Savitz B, Thompson W and Zanis DA 
(2004) Developing employment services for 
criminal justice clients enrolled in drug user 
treatment programmes. Substance Use and 
Misuse, 39(13,14): 2491–2511.
The Ready for Work programme
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Some 20 
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A report commissioned by Ballyfermot STAR to 
assess the needs and well-being of service users 
attending the Ballyfermot-based initiative was 
launched on 15 September 2006.1 The report is 
based on interviews carried out during 2004/05 
with two groups of service users, one group of 45 
attending the Family Support Programme (FSP) and 
a second group of 18 attending the Community 
Employment (CE) programme. The research used 
up to 17 standardised instruments to collect data 
on up to 14 different dimensions of well-being. This 
article will highlight under four headings some of 
the key findings from the report.
Characteristics of service users
Ninety-one per cent of FSP participants and 78% 
of CE participants were parents. Seventy-one per 
cent of FSP participants lived in a two-parent 
household; 57% of the CE group lived in a one-
parent household. The report notes that the rate for 
lone parenthood in Ireland is 21%. CE participants 
were younger and tended to be living with all 
their children or with their parents, whereas FSP 
participants are more likely to be grandparents and 
to have acted in the role of full-time parents to their 
grandchildren. The report noted that nearly one-
third of all service users lived in accommodation 
rented from the local authority – about four times 
the national rate. 
Drug use in families of service users
Eighteen per cent of FSP participants and all the CE 
participants had used drugs. Both groups reported 
drug use by their partners, 13% of the FSP group 
and 22% of the CE group. Of the FSP participants, 
76% reported a high level of drug use by their 
children, and 46% reported that a family member 
was a current active drug user. 
A comparative assessment of the well-being of 
service users
When compared to a representative sample of 
parents in Ireland, Ballyfermot STAR service users 
had:
much higher levels of negative emotions
fewer positive emotions
significantly lower levels of psychological well-
being 
experienced higher numbers of negative life 
events in the past year
significantly weaker support networks
weaker parent-child relationships
higher numbers and frequencies of physical 
symptoms.
On at least one significant dimension of well-being, 
participants on the CE programme fared badly 
compared to the FSP participants. For example, 
CE participants had dramatically reduced physical 
well-being; 90% were unable to work due to 
sickness or disability and 72% reported using 
prescribed benzodiazepines. The report noted that 
significant interventions would be required to bring 
levels of physical well-being among this group 
closer to the norm. These individuals had all been 
active users of illicit drugs and the majority were 
now stable on methadone and availing of the CE 
part-time work and vocational training programme 
to improve their employability. 
However, research has cast doubt on the suitability 
of vocational training programmes for participants 
with questionable claims to stabilisation and poor 
health and physical well-being. For example, 
Kemp and Neale2 pointed out that employability 
programmes can only realistically engage with 
clients who have achieved a consistent state of 
stabilisation and are in good health and secure 
accommodation. 
Influence of drug use on family well-being 
This part of the research focused exclusively on the 
45 participants in the Family Support Programme 
(FSP). A key research question that runs throughout 
this report is: To what extent is the well-being of 
families negatively affected by drug use in the 
family? Nineteen per cent of families attending 
the Ballyfermot STAR centre had experienced the 
death of a family member as a result of drugs, and 
59% of service users had a family member who 
had been imprisoned for using drugs. Furthermore, 
families with a member who used drugs, whether 
active (using illicit drugs) or stable (using prescribed 
drugs), had consistently lower levels of well-being 
than families that were drug free (without either an 
active or a stable drug user in the family).
On the other hand, FSP service users living in drug-
free families had significantly higher levels of well-
being than those living in families where drug use 
was either active or stable. In addition, service users 
living in drug-free families had significantly higher 
levels of well-being than the average Irish parent. 
■
■
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However, the authors noted that, given that these 
data were cross-sectional (collected at one point in 
time) rather than longitudinal (collected at different 
points over time), it was not possible to be certain 
about the direction of the causation. Nonetheless, 
the report makes the case that it seems plausible 
to infer from the data that well-being is influenced 
by drug use, rather than the reverse, since those 
who were currently drug free had previously been 
active or stable. The authors concluded that, on 
balance, it was possible to infer from the data that 
the presence of a drug user in the family had a 
significant negative impact on the well-being of 
other family members. 
This is an important piece of research into an area 
that is now being recognised at policy level and 
was highlighted in a study by Murphy-Lawless3 on 
the impact of drug abuse on families in the north 
inner city of Dublin. The need to respond to the 
problems faced by families affected by drug misuse 
was recognised in the mid-term review of the 
National Drugs Strategy.4 The review recommended 
that a new cross-pillar action be developed 
covering the broad area of family support, under 
which the recommendations of the recent family 
support study by the National Advisory Committee 
on Drugs5 should be implemented. 
It is important for communities that have been 
identified as areas with acute levels of problematic 
drug use and associated levels of socio-economic 
disadvantage, such as Ballyfermot, that policy 
responses remain targeted and sustained towards 
removing disadvantage and reducing the demand 
for illicit drugs. It is likely that such sustained 
and meaningful policy commitment will be met 
with an enhanced neighbourhood solidarity, 
as was reported by some of the participants in 
this study. As this research has also shown, users 
of the Ballyfermot STAR services reported huge 
satisfaction with their neighbourhood compared 
to the norm in Ireland. Moreover, participants on 
the CE programme, despite their own reported 
poor levels of physical well-being, were even more 
satisfied with their neighbourhood than the FSP 
participants. This was the only dimension of well-
being in which service users displayed a level of 
well-being that was higher than the national norm. 
(Martin Keane)
1. McKeown, K and Fitzgerald G (2006) The impact 
of drugs on family well-being. Dublin: Ballyfermot 
STAR.
2. Kemp P and Neale J (2005) Employability and 
problem drug users. Critical Social Policy, 25(1): 
28–46.
3. Murphy-Lawless J (2002) Fighting back: women 
and the impact of drug abuse on families and 
communities. Dublin: Liffey Press.
4. Steering Group for the mid-term review of the 
National Drugs Strategy (2001) Mid-term review 
of the National Drugs Strategy 2001–2008. 
Dublin: Department of Community, Rural and 
Gaeltacht Affairs.
5. Watters N and Byrne D (2004) The role of family 
support services in drug prevention. Dublin: 
Stationery Office. 
Drugs and family well-being (continued)
Rehabilitation Working 
Party: an update 
On 9 November 2006, in response to a 
question in Dáil Éireann, Minister of State 
with responsibility for drugs strategy, Noel 
Ahern TD, stated: ‘ … a working group on 
drugs rehabilitation was set up in September 
2005 under the aegis of my Department 
to develop proposals to augment existing 
rehabilitation services. The working group 
includes representatives from a range of 
Departments and agencies involved in 
delivering rehabilitation services, in addition to 
representatives from the national drugs strategy 
team, the National Advisory Committee on 
Drugs and the community and voluntary 
sectors. The terms of reference of the working 
group are broad and include examining the 
existing provision of rehabilitation services, 
identifying best practice, identifying gaps 
and recommending actions to develop an 
integrated rehabilitation service. Some of the 
group’s key recommendations are likely to 
focus on ensuring that actions 47, 48 and 50 
of the Strategy are met. These actions largely 
relate to providing a continuum of care for 
clients through planned progression paths for 
each problem drug user, while ensuring that 
quality standards are achieved in the services 
provided. The group is also likely to deal with 
wider supports which are needed by recovering 
problem drug users in areas like involvement in 
community employment schemes, educational 
supports and support with progression to 
employment, housing and child care. It will 
also recognise the need to involve the families 
of problem drug users in the process. I expect 
the working group to complete its report by 
the end of the year, with a view to beginning 
the implementation of its recommendations in 
2007. I am aware that the HSE has established 
a working group on residential treatment and 
rehabilitation for substance users. This group, 
on which my Department is represented, 
is examining the residential rehabilitation 
requirements of people involved in all forms 
of substance misuse, including the misuse of 
alcohol. Its report is likely to be available early in 
the first half of next year.’
It is difficult to establish the number of crimes 
that go unreported to the police. Surveys of crime 
victims have been used in other jurisdictions 
to estimate this ‘dark figure’ of crime.1 For 
example, British Crime Surveys conducted at 
regular intervals since 1982 have led to estimates 
that only one in four of the crimes which occur 
appear in official records.2 Other authors have 
suggested that, when petty offences such as 
shoplifting are included, the ‘dark figure’ can be 
as high as eleven times the police figure.3 There 
is evidence to suggest that the ‘dark figure’ may 
be even higher in the case of drug offences and 
drug-related crime. A recent study conducted 
in Dublin’s north inner city highlighted fear of 
reprisal from those involved in the drug trade as a 
significant disincentive to reporting such offences 
to the gardaí.4 
In a unique approach to addressing such 
problems, the Blanchardstown Local Drugs Task 
Force (BLDTF) set up a non-Garda confidential 
phone line to help gather information on local 
drug dealing. The launch of the campaign in 
May and June 2006 involved, in the initial two 
weeks, the distribution of 30,000 brochures, 250 
in-store posters and a local media event. Weeks 
three and four focused on older children and 
younger adults in formal and informal educational 
and community sectors, while peer-education 
teams spoke in schools and community centres. 
Week five involved a retail initiative including over 
twenty businesses – supermarkets and fast food 
outlets – which agreed to distribute campaign 
literature. 
The confidential number was free so as to 
encourage its use by older children and young 
adults. The number was also anonymous so 
people could be reassured that they would not be 
required to be involved in possible ensuing legal 
proceedings. The use of a non-Garda number 
was regarded as important as it was felt that, for 
some local residents, phoning a police number 
would be a serious barrier. The service was open 
24 hours, seven days per week. Also, it was not 
necessary to have witnessed drug dealing directly. 
Callers were encouraged to call with second-hand 
information. The phone lines were managed by a 
professional call centre.
The report of the evaluation of the project was 
launched by Noel Ahern TD, Minister of State 
with responsibility for drugs strategy in November 
2006.5 The report includes findings on the project 
from three sources: daily reports from the call 
center, a report from the Garda Síochána and a 
public survey of a sample of 250 people. Over 
the six-week period 296 calls were received. On 
foot of these, 100 detailed reports were sent to 
the gardaí. The Garda evaluation indicated that 
67% of these reports provided ‘somewhat useful 
or very useful’ information. Cocaine was the 
subject of 42% of reports, followed by cannabis 
(27%) and heroin (17%). These were followed by 
ecstasy (7%), prescription drugs (5%) and steroids 
at 2%. Of the reports that were followed up by 
the drugs unit of Blanchardstown Garda Station, 
17% were referred to other Garda districts, 17% 
resulted in arrests with court cases pending, 7% 
were awaiting further information, 2% were 
being monitored and 59% were part of ongoing 
investigations. The gardaí concluded that the 
project had helped raise awareness of the drug 
situation in the area and had helped identify drug 
dealers unknown to them.
The survey of public opinion provided information 
on local attitudes to the drug situation and the 
future potential for the development of the 
campaign. Included among the survey findings 
were the following:
89% of youths and 70% of adults regarded 
drugs as a ‘very’ or ‘somewhat’ serious 
problem.
46% of youths and 37% of adults responded 
‘yes definitely’ when asked whether the public 
should be encouraged to help gardaí with the 
drugs problem in Dublin 15.
More than half of the respondents 
spontaneously recalled the ‘dial to stop drug 
dealing campaign’. The highest level of recall 
of campaign literature was for the brochures 
delivered door-to-door.
That each call would be treated with absolute 
confidentiality was ‘very important’ for three 
quarters of the sample: 76% of youths and 
73% of adults.
The motivation to call either a Garda or non-
Garda confidential telephone line was similar 
for both youths and adults and primarily 
driven by community spirit.
The inhibitions about calling either 
confidential number related to a dislike or 
disregard for the gardaí, concern about 
anonymity and confidentiality, a reluctance to 
get involved and fear of reprisal.
Drug markets and drug-related crime at a micro-
level can lead to the creation of ‘no-go areas’, 
the development of a culture of fear and the 
erosion of the social bonds which contribute to 
community cohesion. They can also intensify the 
stigmatisation often felt in communities where 
such problems take hold.4 Initiatives such as 
■
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the Blanchardstown ‘Dial to stop drug dealing’ 
project, by seeking to develop a response which 
is sensitive to local conditions, represent an 
innovative approach in this area. Although the 
local campaign was due to end in December 
2006, the steering group overseeing the project 
has recommended that it be adapted and rolled 
out on a national basis. (Johnny Connolly)
1. For a general discussion on the issues which 
arise in the context of crime statistics, see 
Maguire M (1997) Crime statistics, patterns, 
and trends: Changing perceptions and their 
implications, in Mike Maguire, Rod Morgan 
and Robert Reiner (eds) The Oxford Handbook 
of Criminology. For an Irish perspective on 
drug-related crime see Connolly J (2006) 
Drugs and crime in Ireland. Overview 3. Dublin: 
Health Research Board. 
2. Hough J M and Mayhew P (1983) The British 
Crime Survey. Home Office Research Study No. 
76. London: HMSO.
3. Sparks R, Genn H and Dodd D (1977) 
Surveying victims. Chichester: John Wiley.
4. Connolly J (2003) Drugs, crime and community 
in Dublin: Monitoring quality of life in the north 
inner city. Dublin: North Inner City Drugs Task 
Force.
5. Blanchardstown Local Drugs Task Force (2006) 
Blanchardstown Dial to Stop Drug Dealing: 
campaign evaluation executive summary report. 
Blanchardstown: BLDTF.
Dial to Stop Drug Dealing (continued)
Following on from the recommendations of the 
Gaelic Athletic Association (GAA) task force on 
drugs and alcohol (see Drugnet Ireland 18), the 
organisation recently published a guide for GAA 
clubs on developing policy in this area.1 The task 
force recommended that each club develop a 
policy appropriate to their circumstances, and 
the new guide outlines a step-by-step approach 
to achieving this, emphasising the importance 
of involving members in this process. The guide 
contains specific recommendations, such as 
ending the traditional ‘filling the cup’ celebrations 
and phasing out alcohol advertisements on club 
jerseys and grounds. It also provides advice on 
using educational programmes to raise awareness 
of alcohol- and drug-related issues, and on 
responding to evidence of possible problematic 
behaviour among club members. 
The GAA Alcohol and Substance Abuse Prevention 
(ASAP) programme emphasises the importance 
for clubs of developing links with professional 
drug and alcohol services in their local areas to 
assist them in the management of alcohol- and 
drug-related incidents and in the development of 
appropriate policies. To help with this, the guide 
contains a county-by-county listing of drug and 
alcohol services.
The ASAP programme is at an early stage. 
Eventually, each of the country’s 2,500 GAA clubs 
will have an officer to co-ordinate and oversee 
the implementation of its own drug and alcohol 
policy. The new guide provides the template for 
this, but each club will decide what policies are 
appropriate to its particular circumstances and 
local conditions. (Brian Galvin)
1. Murphy B (2006) GAA club manual for dealing 
with drug and alcohol related issues. Dublin: 
Cumann Luthchleas Gael.
For further information, contact:
Brendan Murphy, National Co-ordinator 
ASAP Programme, GAA Connacht Council 
Office, Clare Street, Ballyhaunis, Co. Mayo. 
Tel: (094) 9631804;  
Email: bmurhpy@clg.gaa.ie
GAA publishes guide for clubs
This legal briefing reviews some of the significant drug-
related legislative initiatives introduced during 2006.
On 1 January 2006 the Railway Safety Commission 
was established under the Railway Safety Act 2005.1 
The Commission regulates railway safety in Ireland 
and has wide-ranging powers to monitor and inspect 
railway infrastructure and to take enforcement action 
where necessary. Provisions in the Act relating to the 
testing of safety-critical workers for the presence of 
‘intoxicants’, which include alcohol and drugs and any 
combination of drugs or of drugs and alcohol (Parts 9 
and 10), give the Commission power to approve codes 
of conduct, sampling procedures and support services. 
An order under the Misuse of Drugs Act 1977 
provides that, from 31 January 2006, ‘any substance, 
product or preparation (whether natural or not), 
including a fungus of any kind or description, which 
contains psilocin or an ester of psilocin is a controlled 
drug for the purposes of the Act’.2 The effect of this 
order is to render the possession or sale of so-called 
‘magic’ mushrooms criminal offences under the Act. 
Heretofore, it was illegal to possess or supply magic 
mushrooms in a dried or prepared state but lawful to 
possess and sell them in their natural state.3
The Criminal Justice Act 2006 was signed into law 
by the President on 16 July 2006. On 1 August 2006, 
Michael McDowell TD, Minister for Justice, Equality 
and Law Reform, signed an order bringing into 
operation a number of provisions contained in the Act 
that relate to the jurisdiction of district court judges to 
issue a search warrant when they are outside their own 
district.4 
With regard to organised crime and drugs, the 
Criminal Justice Act 2006 provides a new definition 
of ‘criminal organisation’ as ‘a structured group 
composed of three or more persons acting in concert, 
established over a period of time and having as its 
main purpose or main activity the commission of or 
facilitation of a serious offence’. The Act delineates new 
offences relating to participation in or assisting the 
activities of a criminal organisation. 
The Irish Human Rights Commission (IHRC) has 
raised a number of concerns about some of the 
provisions of the Criminal Justice Act.5 In relation to 
proposals contained in Part II, which add additional 
grounds to the mandatory sentencing guidelines for 
persons convicted in possession of drugs valued at 
€13,000 or more (Criminal Justice Act 1999), the 
IHRC states that it is concerned ‘that the proposals 
in relation to the 10 year mandatory sentence may 
undermine the discretion of the judiciary to ensure 
that the sentence imposed is in line with the principle 
of proportionality, and to ensure that a fair balance 
is struck between the particular circumstances of 
the commission of the offence and the relevant 
circumstances of the person sentenced’ (p.17). With 
regard to the determination of the market value of the 
drugs, the IHRC recommends that an objective expert 
witness be called to give an opinion on the valuation 
of drugs before the court. The IHRC is also of the 
view that the €13,000 valuation for drug trafficking 
offences should be reviewed in light of inflation and 
the current cost of drugs. The Act amends the law 
so that it will not be necessary for the prosecution to 
prove that a person charged with an offence relating 
to the possession of drugs under section 15A of the 
Misuse of Drugs Act 1977 knew that the value of 
the drugs in his or her possession was €13,000 or 
more, or was reckless in that regard. In relation to this 
provision, ‘the IHRC is of the view that the removal of 
the element of knowledge or intention on the part of 
the accused person may raise questions around the 
forseeability of criminal liability. The IHRC recommends 
that the prosecution should be required to prove that 
the accused has reasonable grounds to believe that the 
drugs in his or her possession were worth €13,000 (or 
whatever the limit may be) or more’ (p.17). 
The IHRC has also raised concerns about the proposal 
in the Act to establish a Drug Offenders Register, 
modelled on the Sex Offenders Register provided for 
in the Sex Offenders Act 2001. It states that ‘it is not 
apparent…how a drug offenders register will be an 
effective, necessary or proportionate response’ (p.21) 
to the need to prevent drug trafficking, and it has 
requested further information from the minister on the 
purpose of the proposed register.
Implementation of laws
It was reported on 5 May 2006 that plans are at 
an advanced stage for the extension of the Drug 
Treatment Court to include referrals from all courts 
in the Dublin metropolitan area.6 
Guidelines setting out the functions, composition 
and operation of joint policing committees (JPCs), 
established under the Garda Síochána Act 2005, 
were published in June.7 JPCs are to be established 
in each of the 114 local authority administrative 
areas throughout the State. They will bring 
together representatives from the local authority, 
gardaí, public representatives and representatives 
of the community and voluntary sector to discuss 
and make recommendations on matters affecting 
the policing of the area.8 (Johnny Connolly)
1. S.I. No. 841 of 2005. Railway Safety Act (Part 2) 
(Establishment Day) Order 2005.
2. S.I. No. 55 of 2006. Misuse of Drugs Act 1977 
(Controlled Drugs) (Declaration) Order 2006.
3. Connolly J (2006) Government bans sales of 
‘magic’ mushrooms. Drugnet Ireland, 17: 9. 
4. The need for these provisions arose on foot of the 
Supreme Court judgement in the case of Creaven & 
Ors v. Criminal Assets Bureau & Ors [2004] IESC 92 
(29 October 2004) 
5. Irish Human Rights Commission (2006) 
Observations on additional proposals for amendments 
to the Criminal Justice Bill 2004. Dublin: IHRC.
6. O’Brien C (2006) Drug Treatment Court 
programme to be expanded. Irish Times, (5 May): 
5.
7. Department of Justice Equality and Law Reform 
(2006) Garda Síochána Act 2005: Joint policing 
committee guidelines. Dublin: Department of Justice 
Equality and Law Reform.
8. Connolly J (2006) Guidelines on joint policing 
committees. Drugnet Ireland, 19: 9.
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In October 2006, the European Commission published 
a Special Eurobarometer survey on AIDS prevention.1 
This survey gathered public opinion from 25,000 
respondents in the 25 member states, the four 
acceding and candidate countries, and the non-
government-controlled areas of Cyprus. In Ireland, TNS 
MRBI carried out 1,000 interviews between September 
and October 2005. Results of this survey are compared 
with a Eurobarometer survey on this issue which took 
place in the 15 member states in 2002.2
Respondents’ perceptions about how people catch 
HIV and AIDS
According to the survey report, ‘Europeans know how 
HIV can be contracted but some uncertainty emerges 
when it comes to ways in which the virus cannot be 
transmitted.’ 
Almost all respondents (97%) knew that it is possible 
to contract HIV by an infected needle, by receiving 
infected blood, and by having sex without protection 
with someone who has AIDS or who is HIV positive. 
When asked about ways in which HIV or AIDS cannot 
be transmitted, respondents were more uncertain. 
Only 40% knew that it is not possible to be infected 
with HIV by kissing on the mouth. Almost half (around 
45%) mistakenly believed that it is possible to be 
infected by sharing drinking glasses or toilet seats 
with, donating blood to, or taking care of HIV-positive 
or AIDS patients. There were some large differences 
between the highest and the lowest percentages of 
correct answers given. For instance, 89% of Swedes 
knew that it is not possible to become HIV positive by 
giving blood, compared to 16% of Slovakians. 
Most Europeans knew that it is not possible to contract 
AIDS or HIV by shaking hands with, handling objects 
touched by, or eating a meal prepared by someone 
who has AIDS or is HIV positive. Respondents from 
new member states were more likely than those of 
the old EU15 to give an incorrect answer to questions 
relating to ways of contracting the disease. 
Irish responses tended to fall below the European 
average for correct answers (Table 1). There was a 
greater level of uncertainty about the way HIV and 
AIDS can be contracted, with more ‘possibly’ and 
‘don’t know’ answers throughout. 
New Eurobarometer survey on AIDS 
prevention
Table 1 Respondents’ knowledge about the ways AIDS can be caught
No 
%
Possibly 
%
Yes 
%
Don’t know 
%
Being injected with a needle which has been 
used by someone who has AIDS or who is 
HIV positive
EU* 1 3 94 1
Ireland 1 6 90 4
Receiving blood from someone who has AIDS or 
who is HIV positive
EU 1 3 94 2
Ireland 1 5 91 3
Having sex without protection with someone 
who has AIDS or who is HIV positive
EU 1 3 94 2
Ireland 1 6 90 4
Kissing on the mouth someone who has AIDS or 
who is HIV positive
EU 40 30 24 6
Ireland 28 38 23 11
Drinking from a glass which has just been 
used by someone who has AIDS or who is HIV 
positive
EU 52 27 15 6
Ireland 48 28 11 13
Giving blood EU 54 13 30 3
Ireland 59 14 17 10
Sitting on a toilet seat which has been used by 
someone who has AIDS or who is HIV positive
EU 55 26 13 7
Ireland 51 25 11 13
Taking care of someone who has AIDS or who is 
HIV positive
EU 58 25 12 4
Ireland 58 22 10 10
Eating a meal prepared by someone who has 
AIDS or who is HIV positive
EU 70 17 7 6
Ireland 71 13 4 12
Handling objects touched by someone who has 
AIDS or who is HIV positive
EU 78 13 5 4
Ireland 75 11 4 10
Shaking hands with someone who has AIDS or 
who is HIV positive
EU 83 9 5 3
Ireland 77 12 4 7
*EU figure is the aggregate percentage from 25 member states
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Since 2002, awareness had dropped in Italy, Spain and 
the UK, but levels were notably higher in Portugal and 
Germany and, to some extent, in France and Belgium. 
Irish awareness does not appear to have changed 
significantly over this time.
Changes in respondents’ behaviour since the 
emergence or spread of AIDS
Almost half (48%) of respondents said that the 
emergence of AIDS had led them to take precautions 
in sexual intercourse, and 38% now sought more 
stability in their choice of partners. It had led a small 
minority of respondents to try to ‘avoid certain 
company’ (17%), to take more care over the things 
they touched (14%), and to avoid ‘certain places’ 
(14%). Fewer people in 2005 than in 2002 reported 
taking these precautions (Figure 1). 
Perceived effectiveness of measures undertaken in 
the respondents’ countries
Overall, most Europeans saw measures undertaken 
in their country to stop the spread of AIDS as ‘very 
effective’ or ‘fairly effective’. Almost 70% believed 
that treating and looking after someone with AIDS 
was the most effective measure used. The Irish were 
less positive about the effectiveness of measures 
undertaken in Ireland, with a drop in perceived 
effectiveness since 2002 (Figure 2). 
Respondents’ attitudes to harmonisation of efforts 
within the European Union
With the exception of the UK, Denmark and Spain, 
the majority or respondents (average 87%) in all 
countries were in favour of greater collaboration 
and harmonisation of efforts within the EU in terms 
of funding research to find an AIDS vaccine and in 
the treatment and care for those who have HIV or 
AIDS. They also thought that the EU should launch 
information campaigns on risky behaviour.  
(Mary Dunne)
1. http://ec.europa.eu/public_opinion/archives/ebs/
ebs_240_en.pdf 
2. The 2002 survey was conducted under the 
framework of the Eurobarometer (special 
Eurobarometer 183–2 / Wave 58.2). It is available 
(only in French) at http://ec.europa.eu/public_
opinion/archives/ebs/ebs_183.2_fr.pdf
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Figure 1   Changes in respondents’ behaviour since the emergence and spread of AIDS
Source: AIDS Prevention Eurobarometer 2006
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Figure 2   Perceived effectiveness of measures undertaken in respondents’ countries 
*Sum of percentages of ‘very effective’ and ‘fairly effective’ answers 
Source: AIDS Prevention Eurobarometer 2006
New Eurobarometer survey (continued)
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The Irish Prison Service (IPS) annual report for 2005 
was published in September 2006.1 The aim of 
the IPS healthcare system is to deliver a standard 
of healthcare to all prisoners that is equivalent to 
that available in the wider community. Healthcare 
is provided to prisoners at the level of primary 
care, by general practitioners, nurses and medical 
orderlies.
The mid-term review of the National Drugs Strategy 
in 2005 recommended that the IPS collaborate 
with key stakeholders such as the Drugs Strategy 
Unit of the Department of Community, Rural and 
Gaeltacht Affairs and the National Drugs Strategy 
Team (NDST). Acting on this recommendation, the 
IPS presented relevant issues on the drugs situation 
in prisons to the NDST and the National Advisory 
Committee on Drugs. The NDST now wishes to 
incorporate individual prisons into the work of the 
local and regional drugs task forces.
Drug treatment
A total of nine prisons provide methadone 
treatment, with 1,564 prisoners receiving 
methadone substitution in 2005, an increase of 255 
(16.5%) on the previous year (Table 1). Of these, 
169 individuals received methadone substitution for 
the first time in prison.
In October 2005 the HSE and the IPS awarded a 
joint contract to a pharmaceutical company for 
the supply of methadone. This joint purchasing 
agreement will ensure:
continuity of treatment for prisoners who move 
between the community and prison
■
a regular supply of methadone
significant cost savings to the IPS.
In 2005, a contract was awarded for the provision 
of pharmacy services to Shelton Abbey. Due to the 
lack of professional pharmacy services in prisons, 
the IPS now intends to introduce a contracted 
pharmacy service provided by a community 
pharmacy to all prisons. Such a service will result 
in improved patient care and efficient use of 
medicines.
Other significant developments in the prison 
healthcare system in 2005 were:
A clinical data system which will record and 
store clinical information across the prison 
system was developed.
An overall Strategic Statement which will inform 
the medium-term development and provision 
of prison healthcare was finalised.
A joint initiative between the IPS and the HSE 
South Western Area led to the appointment of 
a consultant psychiatrist in adult addictions. 
This contributes to the healthcare strategy and 
increases the range of in-reach services available 
to prisoners. A similar appointment was made 
in the HSE Northern Area in 2004 to provide 
sessions at the Mountjoy complex.
The role of healthcare managers in the IPS was 
highlighted in the Proposal for Organisational 
Change (which dealt with revised working 
arrangements in prisons), and a clinical nursing 
management structure within the prison system 
is being introduced.
(Siobhán Reynolds)
1. Irish Prison Service (2006) Annual Report 2005. 
Dublin: Irish Prison Service.
■
■
■
■
■
■
Irish Prison Service – Annual Report 2005
IRISH PRISON SERVICE 
ANNUAL REPORT
2005
Table 1 Numbers receiving methadone 
substitution treatment in Irish 
prisons in 00
Prisons Total 
patients
New 
patients
Cloverhill Prison 571 97
Dochas Centre 228 27
Limerick Prison 4 0
Midlands Prison 6 0
Mountjoy Main Prison 511 27
Mountjoy Prison Medical 
Unit
79 5
Portlaoise Prison 2 0
St Patrick’s Institution 1 0
Wheatfield Prison 162 13
Total 1564 169
The aim of the IPS 
healthcare system 
is to deliver 
a standard of 
healthcare to all 
prisoners that is 
equivalent to that 
available in the 
wider community.
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Merchants Quay Ireland (MQI) launched its annual 
review for 20051 on 29 September 2006. Speaking 
at the launch, chief executive Tony Geoghegan said 
that the number of people using MQI’s drugs and 
homeless services had grown last year. 
The city-centre needle exchange and the health 
promotion programmes were particularly busy. 
He said that more than 3,000 people had used 
the agency’s needle-exchange service last year. 
The report shows that a total of 470 new injectors 
presented in 2005, up 6% on 2004. Mr Geoghegan 
said that people tended to inject drugs for a year 
before they sought treatment, and that during 
this period they were putting themselves at risk 
of contracting hepatitis C or HIV. He expressed 
concern at the high number of people accessing 
 
the MQI service and highlighted the lack of 
localised harm-reduction services.
The report also highlights the increasing demand 
for MQI’s homeless services, particularly by people 
from the new EU member states. By September 
2005 there was an average of 20 to 30 eastern 
Europeans attending the service every day. In 
response to this, MQI has produced information 
leaflets in a number of languages and some staff 
have taken language classes.
The types of service offered by MQI and the 
numbers of people accessing them in 2005 are 
shown below. (Siobhán Reynolds)
1. Merchants Quay Ireland (2006) Annual Review 
2005. Dublin: MQI.
Merchants Quay Ireland –  
Annual Review 2005
Service Type of intervention Number of 
participants
Outcomes
Needle exchange 
health promotion 
services
Promoting safer injecting techniques  
HIV and hepatitis prevention 
Safe sex advice 
Information on overdose
3,339 (including 470 
new injectors) 
321 safer injecting 
workshops
Not available
Stabilisation 
services
Methadone substitution 29 Not available
Supportive day programmes 11 Not available
Gateway Programme 33 (average per 
month)
Not available
Counselling Not available Not available
Settlement 
service
Assist service users to access interim 
and long-term accommodation
An average of 80 
service users a month
An average 
of 10 service 
users availed 
of the Tenancy 
Sustainment 
Service each month
Integration 
programmes
Access to transitional accommodation 
(Ballymount House) for up to 24 weeks 
Group and one-to-one therapeutic 
sessions
12 Not available
Training and work 
programmes
FÁS Community Employment scheme 140 70 secured 
permanent 
employment or 
moved to further 
education
Catering training programme 22 20 registered for 
certification for 
FETAC National 
Certificate in 
culinary skills
High Park 17-week, drug-free residential 
programme including individual 
counselling, group therapy, 
educational groups, work assignments 
and recreational activities
51 (of whom 13 
were admitted for 
detoxification)
11 completed 
detox 
St Francis Farm Therapeutic facility offering a 6–12-
month programme
26 12 completed 3 
months or more
Broadcaster George 
Hook, who launched 
the MQI annual 
review (Photo: 
Laurence Boland)
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In November 2006 the Drug Policy Action 
Group (DPAG)1 launched two policy papers in 
Dublin. Policy Paper 1 deals with criminal justice 
drugs policy in Ireland and Policy Paper 2 raises 
a number of questions around the social care of 
drug users in Ireland. This article will focus on 
the latter paper, written by Gemma Cox and 
Fr Peter McVerry – Social care and drug users in 
Ireland.2 
The authors acknowledge that, for a large 
majority of people, social care is provided 
by family, friends and neighbours through 
informal networks of mutual support and is 
supplemented by state-sponsored institutional 
care through the public health system, social 
care services and education, employment and 
housing supports. But, the paper points out, 
very often the most vulnerable members of 
society, including a high proportion of drug 
users, who have the most complex needs, are 
likely to fall between the gaps in services. When 
drug users present for help and support, very 
often to specialist drug treatment agencies, 
a high proportion present with multiple 
problems, including psychological and serious 
mental health problems, employment and 
economic issues, poor living arrangements, 
familial and social relationship difficulties, and 
legal problems. 
The paper claims that the way the specialist 
drug treatment service has evolved in Ireland 
(in a similar way to that of other health and 
social care services) means that it operates 
largely in isolation from other services and is 
generally unable to deliver a continuum of 
care. While the drug treatment service may 
be doing an excellent job in responding to 
people’s addiction problems, there is a lack 
of co-ordination between drug services and 
agencies and other generic social care services, 
such as housing agencies, national training 
and employment agencies and mental health 
services. 
In particular, the authors highlight two vital 
components of social care, employment 
and housing, and argue that, because of the 
uncoordinated nature of social care services 
targeting drug users, these needs are not 
addressed in a meaningful manner. For 
example, the report highlights the strong 
association between unemployment and 
problem drug use, but rightly notes that 
the causal direction of the association is 
complex. Nonetheless, it notes that improving 
employability for problem drug users can be a 
major factor in preventing relapse. Platt’s review 
of treatment outcomes in the US3 also finds an 
association between improved employability 
and reduced relapse. For example: 
Persons in treatment who are employed 
stay in treatment longer and achieve 
better outcomes than their unemployed 
counterparts.
Persons who are regularly employed have 
lower rates of substance misuse than 
those who are sporadically employed or 
unemployed. 
The authors argue that work provides a sense 
of responsibility, personal value, independence, 
security, dignity and a stake in society. This 
is a view shared by problematic drug users 
interviewed by Neale (2002)4 in Scotland, 
who recognised the benefits accruing from 
employment, such as self-esteem, pride and 
a means of avoiding stigma. According to 
Neale, a job was seen by those interviewed as 
central to the process of recovery, since working 
■
■
Drug Policy Action Group 
recommends co-ordinated social care 
for drug users
the authors 
highlight two 
vital components 
of social care, 
employment and 
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provided a distraction and an alternative 
structure to their days. 
On the other hand, the authors note that 
enhancing the employability of drug users has 
not traditionally been a priority for treatment 
and rehabilitation services, where the clinical 
goals of abstinence or stability and maintenance 
are generally given priority. This is a view 
partially articulated in a recent report by the 
National Economic and Social Forum.5 The 
report identifies people with drug and alcohol 
dependencies as one of the marginalised groups 
particularly prone to experiencing labour 
market vulnerability, and states that there is a 
lack of employment support mechanisms to 
assist their progression.
The DPAG recognises that housing is more than 
simply providing a roof over someone’s head. 
It is also about providing security, privacy and a 
space to develop. Housing is a vital component 
of social care and often the key to independent 
living. For many problem drug users, family 
and friends provide the main form of social 
care in terms of housing; however, living in 
the family home does not always work out. 
Research by Houghton and Hickey (2000)6 and 
O’Brien et al. (2000)7 highlights the association 
between problem drug use and family conflict 
and relationship breakdown in the home, 
often leading to those with addiction problems 
experiencing homelessness. 
The paper concludes with five 
recommendations; the DPAG believes that, 
where a commitment is given to these 
recommendations, benefits will occur at policy, 
organisational and service-user level. The 
recommendations are reproduced below.
1. The DPAG recommends an understanding 
of ‘complex needs’ which takes into account 
that each separate need interlocks with all 
of an individual’s other needs and cannot 
be adequately addressed in isolation from 
those other needs
2. The DPAG recommends that social care 
providers prioritise the importance of, and 
agree upon a strategy to develop, a strong 
organizational commitment to interagency 
work, which collectively will enhance the 
provision of social care services in Ireland.
3. The DPAG recommends the development 
of an interagency strategy to provide 
accessible entry to and retention within and 
across social care services in Ireland. 
4. The DPAG recognises the importance 
of service user involvement in the 
development and implementation of 
existing and emerging models of social care 
delivery for problem drug users.
5. The DPAG believes that a published national 
audit of social care services/agencies is a 
necessary first step towards highlighting the 
current state of affairs, progress made and 
necessary improvements. 
The presentation of this paper in a public forum 
provided an opportunity to discuss and debate 
the merits or otherwise of the central claims 
contained therein. The paper challenges both 
policy makers and service providers to consider 
ways of addressing the complex needs of drug 
users within a multidisciplinary social care 
model. Two elements of a social care approach 
are user involvement and inter-agency working. 
Such an approach integrates drug treatment 
services with employment and housing services. 
(Martin Keane)
1. For more on the DPAG, see  
www.drugpolicy.ie
2. Cox G and McVerry P (2006) Social care and 
drug users in Ireland. Policy Paper 2. Dublin: 
Drug Policy Action Group. 
3. Platt JJ (1995) Vocational rehabilitation of 
drug abusers. Psychological Bulletin, 117(3): 
416–433.
4. Neale J (2002) Drug users in society. 
Basingstoke: Palgrave Macmillan.
5. National Economic and Social Forum (2006) 
Creating a more inclusive labour market. 
Report 33. Dublin: National Economic and 
Social Development Office.
6. Houghton FT and Hickey C (2000) Focusing 
on B&Bs: the unacceptable growth of 
emergency B&B placement in Dublin. A Focus 
Report. Dublin: Focus Ireland. 
7. O’Brien J, Waldron AM, Tobin G, McQuaid 
P, Perot S, Pigott-Glynn L and Houghton F 
(2000) The mental and physical health and 
well-being of homeless families in Dublin: a 
pilot study. Dublin: Focus Ireland. 
Drug Policy Action Group (continued)
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Keep up to date with online information in the drugs field.
There is a great variety of freely available online content providing very useful information in the substance 
use and addiction fields. In this issue of Drugnet Ireland we present a sample of websites in the UK which 
may complement the information sources you currently use.
Daly Dose www.dailydose.net
Daily Dose was launched in January 2001 and claims to be the world’s leading news service on drug and 
alcohol misuse. The website is updated daily and provides links to a range of relevant material from specialist 
organisations and the popular media from around the world. Daily Dose is maintained by Wired, a voluntary 
organisation comprising people working in the drugs field. According to their website (www.wiredinitiative.
com/index.htm) ‘Wired is a grass roots initiative that merges real world activities with an exceptionally high 
profile web based communication system, for the purpose of disseminating information, providing support, 
education and training, conducting research, and amplifying the capacity of already successful programmes 
to reach their audiences.’
Daily Dose also includes a Weekly Dose with links to the highlights of the week, an archive of published 
items and an archive of links to specialist reports and papers.
Drink and Drugs News www.drinkanddrugs.net/
Drink and Drugs News is a fortnightly free magazine for those working in the drugs field and in the wider 
health, social care and criminal justice fields who deal with drug and alcohol issues in the course of 
their work. It is published by the Federation of Drug and Alcohol Professionals, Wired and CJ Wellings, a 
publishing company. It provides news from the field, feature articles, professional advice, policy analysis and 
other useful material.
The National Documentation Centre on  
Drug Use
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Federation of Drug and Alcohol Professionals www.fdap.org.uk
The Federation of Drug & Alcohol Professionals (FDAP) is the professional body for practitioners in the 
substance use field in the UK. The FDAP works to help improve standards of practice in dealing with people 
with drug and alcohol problems. The website contains up-to-date information on training, professional 
qualifications and standards in the field.
National Treatment Agency www.nta.nhs.uk/
The National Treatment Agency (NTA) is a special health authority created by the British Government in 
2001 to improve the availability, capacity and effectiveness of treatment for drug misuse in the UK. Its goal 
is to ensure that more treatment, better treatment and fairer treatment is available to all those who need it. 
The site contains a great deal of valuable information on treatment services in the UK as well as publications 
and information on policy developments. (Brian Galvin)
National Documentation Centre (continued)
NDC electronic Newsletter
Do you want to stay up to date on current news relating to drug use in Ireland?
The NDC e-newsletter provides news and information on new publications and selected 
parliamentary debates relating to the drugs issue on a monthly basis to all subscribers. The 
newsletter is emailed directly to your desktop and has substantial links to full-text publications 
and other news sources. Please email Louise Farragher louise@hrb.ie if you wish to subscribe to 
the e-newsletter.

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National Documentation Centre (continued)
Recent visitors to the NDC
Students from the UCD Diploma in community drugs work (An Cosán/The Shanty Education and 
Training Centre)
Students from the UCD Diploma in community drugs work (Urrús/Ballymun Youth Action Project)
Students from the TCD Diploma in addiction studies
On 24 August 2006 the Fourth Annual Report of the 
Inspector of Prisons and Places of Detention for the 
Year 2004–2005 was published. It states that, ‘One of 
the greatest problems in prisons is the drug culture’ 
and ‘there should be no drugs in prisons’. To this end, 
it recommends that ‘sniffer dogs be used to deal with 
all persons (not merely visitors) entering the prison’. 
www.justice.ie 
On 1 September 2006 the Report of the Commission 
of Investigation (Dean Lyons Case) was released. 
It concludes that there was no deliberate attempt 
to undermine the rights of Dean Lyons. Instead, the 
report concludes that ‘inappropriate leading questions 
were inadvertently asked by interviewing Gardaí’. A 
copy of the report has been sent to the expert group 
set up in light of concerns arising from the case. It will 
report to the Minister for Justice, Equality and Law 
Reform on the adequacy of Garda training, protocols, 
regulations and procedures in assessing the fitness of 
persons to be interviewed. www.justice.ie 
In September 2006 the UN Committee on the Rights 
of the Child (CRC) considered Ireland’s second 
periodic report, submitted under Article 44 of the 
Convention on the Rights of the Child (CRC/C/IRL/
CO/2). Among its Concluding Observations, the 
Committee recommends that Ireland strengthen its 
efforts to address alcohol consumption by children. 
It also expresses concern about the apparent link 
between underage substance abuse and the suicide 
rate. www.ohchr.org/english/bodies/crc/ 
In September 2006 the National Office for Suicide 
Prevention (NOSP) published its first annual report, 
for 2005. In relation to alcohol and substance abuse, 
the report states that, ‘Issues around the risk of alcohol 
and substance abuse are routinely incorporated into 
awareness training delivered by the HSE Resource 
Officers for Suicide Prevention.’  
www.nosp.ie 
On 1 October 2006, World Hepatitis Awareness Day, 
the Central and Eastern European Harm Reduction 
Network (CEEHRN) released a fact sheet entitled 
Hepatitis C among drug users in the new EU member 
states and neighbourhood. The eight-page document 
contains recommendations for action by different 
groups, including policy-makers, intergovernmental 
and international agencies, health care authorities, 
low-threshold and other health service providers, 
pre-trial detention and imprisonment institutions, and 
researchers.  
www.ceehrn.org/hepatitis 
On 5–7 October 2006 the 9th Annual European 
Conference on Drugs and Infection Prevention in 
Prisons was held in Ljubljana, Slovenia. Organised 
by the European Network on Drugs and Infection 
Prevention in Prison (ENDIPP), this conference focused 
on ‘bridging the gap’ – analysing the barriers to 
providing an equivalence of care inside prisons to that 
which is available outside. www.endipp.net 
On 9 October 2006 A Cross-Border Organised Crime 
Assessment 2006 was released. Based on intelligence 
and information provided by state agencies on both 
sides of the border (including police, customs, asset 
recovery), the report looks at criminal gangs on both 
sides of the border, the impact of the border on 
criminal activity, and the costs of organised crime. 
It states that the border has little or no effect on the 
distribution of illicit drugs. While there are differences 
in the extent of the drugs markets north and south of 
the border, there remain strong cross-border links with 
networks of traffickers from both sides of the border 
working in co-operation to import and distribute 
drugs. www.justice.ie 
On 24 October 2006 the European Commission 
adopted a Communication setting out an EU strategy 
to support member states in reducing alcohol-related 
harm (COM/2006/0625 final). The priorities identified 
in the Communication are to: protect young people 
and children; reduce injuries and deaths from alcohol-
related road accidents; prevent harm among adults 
and reduce the negative impact on the economy; raise 
awareness of the impact on health of harmful alcohol 
consumption; and help gather reliable statistics.  
www.europa.eu/health/ 
On 26–28 October 2006 Correlation, the European 
Network for Social Inclusion and Health, hosted a 
seminar in Dublin Castle on Impacting policy – making 
voices heard. Working in subgroups and providing 
skill-building through workshops, the seminar 
attempted to facilitate exchange of expertise from 
service users and professionals to policy makers and 
vice versa. A limited number of 50-70 participants 
were carefully selected so as to give representatives 
from all 25 EU member states and all professional 
backgrounds the chance to join in. Best practice 
examples were selected from integrative work for the 
marginalised in three fields, including work in relation 
to drug users. www.correlation-net.org 
On 27 October 2006 the Central Statistics Office 
(CSO) published the reported crime statistics, 
including drug-related crime, for the 3rd quarter of 
2006.This publication marked the formal transfer of 
responsibility for the published results from An Garda 
Síochána to the CSO. The CSO has established an 
Advisory Group to review the current methodologies 
for the analysis and presentation of the data, with a 
view to being able to ‘better align crime statistics with 
public and specialist user needs’. www.cso.ie 
On 5 December 2006 Suboxone (buprenorphine 
and naloxone combined) was the subject of a 
parliamentary reply by Minister for Health and 
Children, Mary Harney TD. She stated: ‘Suboxone 
has recently been granted an EU license [sic] via 
central procedure by the EMEA, and preliminary 
studies have shown that the combination drug is as 
effective as Subutex (buprenorphine alone) in the 
management of opioid dependence and that it has 
less abuse potential. My Department is considering the 
implications of the introduction of the combination 
drug Suboxone and its use as a possible treatment for 
opiate dependency. In that context, my officials will 
be meeting the license holders, Schering-Plough in 
the coming week to discuss the best approach on its 
probable Irish launch in early 2007.’ www.oireachtas.ie 
(Compiled by Brigid Pike)
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Books
Drugs: policy and politics
Hughes R, Lart R and Higate P (eds) 
Open University Press 2006, 140 pp.  
ISBN-13: 978 0 335 21616 1 (paperback)
This 140-page book provides a set of tools with 
which to think about the complexity of drug use, 
through discussions of broader social policy and 
of the criminal justice and health policy fields. It 
concentrates on policy as developed in the UK 
and Europe. A theme common to all contributors 
is the need for policy responses to reflect the 
social diversity of drug users.
In Chapter 1 Joanne Neale considers the concept 
of social exclusion. She argues that ‘where 
social exclusion and drugs appear together, only 
problematic drug use is … considered’. She goes 
on to argue that placing the problem drug user 
within the social exclusion framework masks the 
fluidity and dynamism of individuals’ everyday 
experience and reduces the scope for effective 
policy responses. The authors of chapters 2–4 
examine the discourses surrounding three specific 
population groups and their drug use – Trish 
Harding on women, Margaret Melrose on youth, 
and Kazim Khan on those defined by their racial 
or ethnic identity – and all emphasise the need to 
consider drug-using members of these groups in 
their wider social context. 
In chapters 5 and 6 the authors problematise 
the relations between drugs and the law, and 
between drugs and the criminal justice system. 
In tackling the moral debate concerning the 
legal control of drugs, Mike Shiner argues for a 
reconfiguration of drug-related harm and the 
law through development of a restorative justice 
system that combines care and control. Rhidian 
Hughes and Nerys Anthony stress the difficulties 
of understanding drugs and crime as causally 
linked, again arguing that drug users need to be 
located in their broader social contexts and that 
the diversity of drugs users and drug use needs to 
be taken into account.
In Chapter 7 Rachel Lart explores the way drugs 
policy can be seen to mirror broader concerns and 
directions in health policy. Central themes include 
the relationship between the medical profession 
and the state, the development of coordinating 
structures across sectors and between levels of 
government, and the growing importance of 
evidence-based knowledge as a basis for policy. 
In chapter 8 Henri Bergeron and Paul Griffiths 
make three key points about EU drug policy: 
until recently the idea of a common European 
drug policy was more rhetoric than reality; 
European drug policy was characterised by 
diversity rather than homogeneity; and that a 
‘drift to convergence’ might be happening as a 
consequence partly of concern about the spread 
of HIV and partly a concern about public security, 
criminal activities and drugs. 
Guidance for the 
measurement of 
drug treatment 
demand
Toolkit Module 8 
Global Assessment 
Programme on Drug 
Abuse in collaboration 
with the European 
Monitoring Centre 
for Drugs and Drug 
Addiction 
United Nations, 2006
Toolkit Module 8 is designed to improve common 
standards for collecting and monitoring data on 
drug treatment demand. It is intended to help 
UN member states to develop drug information 
systems that are culturally appropriate and 
relevant, to ensure that existing systems conform 
to internationally recognised standards of good 
practice and to focus on the harmonisation of 
drug abuse indicators. It incorporates experiences 
of major ongoing treatment information systems 
and provides concrete guidelines for establishing 
and managing systems to facilitate comparative 
data analysis.
The module describes a dual approach to 
developing a drug information system, one that 
incorporates an operational perspective (the 
ground-level, practical or ‘bottom-up’ approach) 
and an organisational perspective (the political 
or ‘top-down’ approach). Chapter II sets out the 
benefits of collecting drug treatment data and 
describes some of the limitations that may apply. 
The remaining five chapters outline the logical 
stages in the development of a successful system 
under the following headings: Building your 
foundation; Data issues; Implementation; Analysis 
and reporting; and Maintenance and evaluation.
Drugs of abuse  
(2nd edition)
Wills S 
Pharmaceutical Press 
2005, 399 pp. 
ISBN 0 85369 582 2 
(paperback)
The author attempts 
to put the importance 
of drug abuse as a 
world health problem 
into perspective in 
the opening chapter 
Recent publications
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of this book. He points out that the number of 
people who die because of the effects of tobacco 
and alcohol – which are legal substances in most 
countries – far exceeds the number killed by illegal 
drugs. The introduction goes on to discuss some of 
the terms and concepts used in the book, such as 
‘abuse’, ‘dependence’, ‘harm reduction’, ‘polydrug 
use’ and ‘psychoactive drugs’, and describes 
the legal implications of drug abuse. Chapter 2 
deals with the injection of drugs and the dangers 
arising. Each of the next 17 chapters deals with 
a particular drug. Those covered include opioids, 
cannabis, cocaine, amphetamines, ecstasy, LSD, 
volatile substances, performance-enhancing drugs, 
over-the-counter and prescription medicines, 
plants and fungi, caffeine, nicotine and alcohol. 
These chapters give concise information under 
the following headings: history, effects sought, 
administration, pharmacology, adverse effects, 
dependence, interactions with medicines, use 
and concurrent illness, and pregnancy and 
breastfeeding.
Drugs of abuse has been comprehensively revised 
since the first edition, and includes new chapters 
on gamma hydroxybutyrate and on the internet 
as an information resource. Also covered are the 
prevalence of drug use, a detailed assessment 
of side effects, and interactions between illicit 
drugs and conventional medicines. The book is an 
accessible source of detailed information presented 
in a concise way. It will be of interest to healthcare 
professionals and those working with drug users in 
the community.
Alcohol and crime
Dingwall G 
Willan Publishing 2006, 
216 pp. 
ISBN 1 84392 167 7 
(hardback)
This book examines 
the nature of the 
connection between 
alcohol and crime, and 
the way the criminal 
justice system responds 
to those who offend 
after consuming 
alcohol. The author claims that much of the 
research in this area is narrow in focus. He draws 
on a wide range of sources and research findings, 
and sets the subject within a broader comparative 
context. He sets out to critically review this 
literature, consider the policy implications that 
arise from it, and suggest a principled approach to 
those involved in alcohol-related crime. Alcohol and 
crime will be useful reading for anybody concerned 
with the issue and its many social, legal and 
criminological ramifications.
The introductory chapter gives an overview of 
habits and patterns of alcohol consumption in 
the UK. The next two chapters consider the link 
between alcohol and crime: chapter 2 analyses 
a number of studies that have considered 
the extent to which offenders drink prior to 
offending; chapter 3 looks at the ways in which 
the consumption of alcohol may increase 
the likelihood of offending and concludes by 
considering some of the methodological problems 
that arise in trying to establish a causal link. 
Chapter 4 looks at ways of preventing and policing 
alcohol-related crime and disorder. The next 
two chapters give a detailed critique of the legal 
response to alcohol-induced offending: chapter 5 
deals with substantive criminal liability; chapter 6 
is concerned with sentencing. Chapter 7 concludes 
by considering the UK government’s recent 
strategies to reduce alcohol-related crime and the 
disorder associated with it, and suggests areas that 
still need to be addressed. 
Journal articles
The following abstracts are from a selection of 
articles relating to the drugs situation in Ireland 
and recently published in international journals.
Trends in medical student use of tobacco, 
alcohol and drugs in an Irish university,  
1973–2002 
Boland M, Fitzpatrick P, Scallan E, Daly L, Herity B, 
Horgan J and Bourke G 
Drug and Alcohol Dependence 2005; 85(2): 
123–128 
Questionnaire surveys of medical students in an 
Irish university were carried out in 1973 (n = 765), 
1990 (n = 522) and 2002 (n = 537). This research 
reports on changes in tobacco smoking, drinking 
and drug use in these three surveys. Among 
western students, the estimated prevalence of 
current smoking declined from 28.8% in 1973 
to 15.3% in 1990 to 9.2% in 2002 (p < 0.001), 
falling in both males (p < 0.001) and females 
(p < 0.01). The percentage of ex-smokers rose 
from 5.9% to 15.1% between 1990 and 2002, 
corresponding to the decline in current smokers. 
The prevalence of current drinkers increased over 
the period, to 82.5% among western students in 
2002 (p < 0.05); female drinking had increased 
steadily since 1973 (p < 0.001), and the overall 
proportion of CAGE-positive drinkers had risen 
since 1990 (p < 0.001). The mean weekly alcohol 
consumption had risen in both sexes since 1990 
(from 14.3 to 19.4 units in males, p < 0.01; from 
6.0 to 9.5 units in females, p < 0.001). Despite the 
decrease in smoking rates, the research showed an 
increase in alcohol and drug consumption between 
1973 and 2002. Personal misuse of addictive 
substances by doctors may mean that doctors will 
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fail to take misuse by patients seriously. The need 
for preventative and ameliorative action during 
the medical school years is clear.
HIV infection among heroin users and area of 
residence
Long J, Keenan E, Grogan L, Mullen L, Barry J and 
Sinclair H 
Irish Medical Journal 2006; 99(8): 230–233
The aim of this study was to develop a hypothesis 
to explain the link between HIV prevalence and 
area of residence. The study was conducted in 
two parts, using two existing data sources. In Part 
1, the bloodborne viral test status and test results 
of a sample of clients attending treatment in 
December 2001 in two areas of Dublin, an inner 
city area (Dublin 8) and a suburban area (Dublin 
24), were extracted from the Bloodborne Viral 
Status Dataset created by Grogan. In Part 2 the 
characteristics of heroin users seeking treatment 
for the first time at treatment services in their 
respective areas of residence, Dublin 8 or Dublin 
24, between 1997 and 2000 were examined, 
using data from the National Drug Treatment 
Reporting System. A higher proportion of heroin 
users in Dublin 8 had HIV and hepatitis C than 
did their counterparts in Dublin 24. The analysis 
suggests that heroin users in Dublin 8 were more 
likely both to have ever used cocaine and to have 
used heroin daily than were those who lived in 
Dublin 24. Also, a higher proportion of injectors 
living in Dublin 8 used heroin and cocaine 
concurrently than did their counterparts in Dublin 
24. In both samples, heroin users who lived in 
Dublin 8 were older than those who lived in 
Dublin 24. The findings led to a hypothesis: ‘The 
risk of acquiring HIV is associated with area of 
residence and may be linked to cocaine use.’
Completeness and accuracy of the drug 
treatment reporting system in Dublin, Ireland
Kavanagh P, Long J and Barry J 
Irish Journal of Medical Science 2006; 175(3): 
52–56
The National Drug Treatment Reporting System 
(NDTRS) is the Irish treated drug misuse 
surveillance system. The aim of this study was 
to measure the completeness and accuracy of 
the NDTRS. The authors conducted a cross-
sectional survey of clinical records and matching 
NDTRS reporting forms of a random sample 
of 520 clients attending four Dublin treatment 
centres. Using clients’ clinical records as the gold 
standard, system completeness (proportion of 
sample reported to the NDTRS) and accuracy 
of selected variables (proportion of reported 
clients’ information on the NDTRS that matched 
clinical record information) were measured; 
452/520 (87%) selected records were retrieved. 
The NDTRS was only 61.1% complete (95% 
CI 56.5–65.5); completeness differed across 
treatment centres (21.8%–85.6%, p<0.0001) 
and was greater for new and returning clients 
than for continuing clients (81.7% versus 
53.9% respectively, p<0.0001). Problems were 
identified with the accuracy of some key variables. 
Urgent actions have been taken to improve the 
completeness and accuracy of the reporting 
system.
International study of heavy drinking:  
attitudes and sociodemographic factors in 
university students
Dantzer C, Wardle J, Fuller R, Pampalone SZ and 
Steptoe A 
Journal of American College Health 2006; 55(2): 
83–89
The authors studied the prevalence of heavy 
drinking among students in 21 developed and 
developing countries, using an anonymous 
survey of 7,846 male and 9,892 female students 
aged 17 to 30 years. There were wide variations 
among countries in the prevalence of drinking, 
and the highest rates of heavy drinking (defined 
as 5 or more drinks for men and 4 or more drinks 
for women on at least 1 occasion over the past 
2 weeks) were reported in Belgium, Colombia, 
Ireland, and Poland (men), and Ireland and 
England (women). Heavy drinking was associated 
with living away from home, having a wealthier 
family background, and having well-educated 
parents. Beliefs about the dangers to health of 
excessive consumption were negatively related 
to heavy drinking. Heavy drinking is a concern 
among students in several countries and is 
associated with greater affluence. Challenging 
beliefs concerning health risks is a crucial aspect of 
prevention in this population.
Volatile substance abuse: A review of findings 
in ESPAD 2003 
Ives R 
Drugs: education, prevention and policy 2006; 
13(5): 441–449
This article analyses data relating to volatile 
substance abuse (VSA) from the Report on the 
2003 European School Survey Project on Alcohol 
and other Drugs (ESPAD). ESPAD is a survey 
of 15–16-year-old students in 35 European 
countries, including Ireland. The survey asked: 
‘On how many occasions (if any) have you sniffed 
a substance (glue, aerosols, etc.) to get high?’ 
The lifetime experience of VSA (i.e. whether they 
had ever tried VSA) among students in the 35 
countries varied from 2% (in Romania) to 22% (in 
Greenland). In Ireland the figure was 18%, down 
from 22% at the time of the 1999 ESPAD survey.
The author notes that ‘much VSA is experimental 
and many of those who try “sniffing” only do so 
once or twice’. As a result, lifetime prevalence 
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figures may be high while current use may be low. 
In Ireland, current use, i.e. 12-month prevalence, 
was 10%. The highest 12-month prevalence 
occurred in Greenland (16%). In Ireland, 30-
day prevalence was 3%. The highest 30-day 
prevalence occurred in Cyprus and Croatia (6%). 
In Ireland, girls reported considerably higher 
lifetime misuse than boys (21% versus 14%). The 
author notes that students in Ireland were most 
likely to report that obtaining volatile substances 
was very or fairly easy, and suggests that the 
association between prevalence and availability 
needs to be investigated further.
Hepatitis C infection among injecting drug 
users in general practice: a cluster randomised 
controlled trial of clinical guidelines’ 
implementation
Cullen W, Stanley J, Langton D, Kelly Y, Staines A 
and Bury G 
British Journal of General Practice 2006; 56(532): 
848–856
Hepatitis C is a common infection among 
injecting drug users and has important 
implications for general practice. Although several 
clinical guidelines concerning the infection have 
been published, their effectiveness has yet to be 
tested. The aim of this research was to assess the 
effectiveness of a general practice-based complex 
intervention to support the implementation of 
clinical guidelines for hepatitis C management 
among current or former drug users attending 
general practice. The study design used was a 
cluster randomised controlled trial in general 
practices in the Eastern Regional Health Authority 
area of Ireland.
Twenty-six practices were randomly allocated 
within strata to receive the intervention under 
study or to provide care as usual for a period 
of six months. There was screening for patients 
attending general practice for methadone 
maintenance treatment for hepatitis C and 
referral of anti-HCV antibody-positive patients to a 
specialist hepatology department for assessment. 
The research concluded that, at study completion, 
patients in the intervention group were 
significantly more likely to have been screened for 
hepatitis C than those in the control group, odds 
ratio adjusted for clustering 3.76 (95% confidence 
interval [CI] = 1.3 to 11.3) and this association 
remained significant after adjusting for other 
potentially confounding variables, using multiple 
logistic regression, with the odds ratio adjusted 
for clustering 4.53 (95% CI = 1.39 to 14.78). 
Although anti-HCV antibody-positive patients in 
the intervention group were more likely to have 
been referred to a hepatology clinic, this was not 
statistically significant (p = 0.06).
Early initiation of cannabis use: a cross-national 
European perspective
Kokkevi A, Nic Gabhainn S and Spyropoulou M 
Journal of Adolescent Health 2006; 39(5): 712–9
This study examines the relationship of the early 
initiation of cannabis use with other high risk 
behaviours and with psychosocial and health-
related correlates in 15-year-old adolescents in 
six European countries, including Ireland. This 
study reports data collected through anonymous 
questionnaires self-completed in classrooms 
in 2001–2002 as part of the Health Behaviour 
in School-aged Children (HBSC) survey. Using 
descriptive and multivariate analyses, differences 
between countries in age of first cannabis use and 
associations with health and related psychosocial 
variables were measured and assessed. The 
prevalence of lifetime and last-year cannabis use 
ranged from 30.7% and 27.5% respectively in the 
Czech Republic to 5.4% and 4.1% respectively 
in Greece. In Ireland, lifetime and last-year 
prevalence were 19.9% and 18.3% respectively. 
Age at first use was lower in the high-prevalence 
countries than in countries with lower prevalence. 
For 15-year-olds, frequent use of tobacco and 
alcohol and other risk behaviours were correlated 
with early (13–15 years old) and especially very 
early (≤ 13 years old) cannabis initiation. Early 
cannabis use was almost uniformly associated with 
higher odds of more frequent use of cannabis 
and other substances, and with a common set 
of other problems. The authors conclude that 
prevention of drug abuse must commence in pre-
adolescence.
Tipping the balance? An Irish perspective on 
Anderson and Baumberg
Butler S 
Drugs: education, prevention and policy 2006; 
13(6): 493–497
This brief comment on Anderson and Baumberg’s 
(2006) review of alcohol in Europe looks at this 
report from an Irish perspective, with a view to 
assessing its impact on the alcohol policy debate 
which has been a feature of Irish society over 
the past decade. It is argued that the review’s 
empirical data and the accompanying policy 
recommendations are already broadly familiar to 
Irish stakeholders in the alcohol policy process, 
but that the provenance of this report, prepared 
for the European Commission, creates further 
potential to tip the balance of Irish alcohol policy 
in the public health direction espoused by its 
authors.
(Compiled by Joan Moore, Brigid Pike and Louise 
Farragher)
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Drug strategies broadening in scope
Cited from Drugnet Europe No. 56,  
October–December 2006
An in-depth analysis of drug policy published 
by the EMCDDA this year alongside the 2006 
Annual report, reveals that there are strong signs 
of a broadening of the scope of drug strategies 
to encompass licit addictive substances, such as 
alcohol, tobacco and medicines, as well as illicit 
drugs. Over two-thirds of the countries surveyed 
now either cite both types of substance explicitly 
in their drug policy documents or include links to 
licit substances in the context of prevention and 
treatment. 
In his message launching the report, EMCDDA 
Director Wolfgang Götz referred to this as ‘clearly 
a timely development when the multiple use of 
licit and/or illicit substances (‘polydrug use’) is 
becoming ever more visible within the European 
drug culture’. The EMCDDA currently faces the 
challenge of monitoring a much broader spectrum 
of substances than a decade ago and polydrug 
use presents big challenges to drug monitoring 
systems that traditionally have focused on the 
use of individual substances. ‘Developing new 
methodologies to understand this pattern of drug 
use must be high on our future agenda’, said 
the Director, ‘if we are to meet the needs of the 
growing number of people whose problems stem 
from using a range of drugs’ 
Harm-reduction measures may be failing women
Cited from Drugnet Europe No. 56,  
October–December 2006
In all EU countries, more men than women die 
from drug overdose, with women accounting for 
between 7% and 35% of drug-related deaths, 
depending on the country. However the review 
points to ‘notable differences’ between the genders 
in drug-related death trends. While overdose 
deaths in the EU fell among males by around 30% 
between 2000 and 2003 (EU-15), the number of 
deaths reported among females fell by only 15% 
over the same period. This raises the question of 
whether harm-reduction measures targeted at high-
risk drug users are impacting less on women than 
on men. 
Concerns also surround the relatively high rates 
of HIV infection found among women who inject 
drugs. Female injecting drug users (IDUs) are more 
often involved in sex work and are more vulnerable 
to HIV infection. Recent data from studies of IDUs 
in nine EU countries showed HIV prevalence to be 
on average 13.6% among male IDUs and 21.5% 
among females. The EMCDDA warns that although, 
overall, more men inject drugs and die from using 
them, one cannot ignore the fact that female 
injectors may be at greater risk and harder to reach. 
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January 2007
Managing the performance, safety and health 
risks of employee drug and alcohol use 
Organised by/Contact: Anita Furlong, Conference 
Administrator, EAP Institute, 143 Barrack Street, 
Waterford, Ireland 
Tel: +353(51)855733 
Fax: + 353(51)879626 
Email: anita@eapinstitute.com 
www.eapinstitue.com
Thursday 18 January 2007  
Venue: Ramada Viking Hotel, Waterford
Thursday 15 February 2007  
Venue: Heritage Hotel, Portlaoise
Thursday 8 March 2007  
Venue: Radisson Hotel, Galway
Information: The Safety, Health and Welfare at 
Work Act 2005 was signed into law in June 2005. 
The Act requires employees not to be under the 
influence of intoxicants (defined as drugs and 
alcohol) to the extent that they endanger their own 
or another person’s safety at work. The purpose 
of this seminar is to outline the impact of drug 
impairment in the workforce and give practical 
guidance on the recognition and treatment of 
employees whose behaviour presents risks to 
themselves and others.
February 2007 
9 February 2007 
Children affected by alcohol
Venue: Brunei Gallery, Thornhaugh Street, London 
Organised by/Contact: Adriana Fabin, NOFAS-
UK, The National Organisation For Fetal Alcohol 
Syndrome-UK, 14-B Hoop Lane, London NW11 8JL. 
Tel: +44 (0)20 8458 5951 
Email: nofas-uk@midlantic.co.uk  
www.nofas-uk.org 
Information: As binge drinking among young 
women increases, society is facing increasing 
risks of children being born with lifelong alcohol 
related brain damage and a spectrum of alcohol 
related disabilities. Prenatal exposure to alcohol can 
cause: learning disabilities; hyperactivity; attention 
and memory deficits; inability to manage anger; 
difficulties with problem solving; and prenatal and 
postnatal growth deficiencies. This conference is a 
response to growing needs of people that care for 
and work with children and adults whose mental 
health was in some way affected by prenatal 
alcohol exposure.
28 February 2007 
Dual Diagnosis and the Criminal Justice System
Venue: ORT House Conference Centre, London 
Organised by/Contact: Henry Ledden, Events 
Marketing Assistant, Pavilion, Richmond House, 
Richmond Rd., Brighton, East Sussex BN2 3RL, UK 
Tel: +44 (0)1273 666706 
Fax: +44 (0)1273 625526 
Email: henryl@pavpub.com  
www.pavpub.com 
Information: Workers from the mental health and 
substance misuse sectors are increasingly aware 
of people having co-existing mental health and 
substance misuse needs, particularly in the criminal 
justice system. There is an urgent need for joined 
up interventions between all partners and better 
liaison with community agencies. This conference 
will explore how clients with dual diagnosis are 
treated in different aspects of the criminal justice 
system, and identify areas of good practice. The 
day will be of interest to both managers and 
frontline workers and will include a strong practical 
element.
March 2007 
12–16 March 2007 
50th Session of Commission on Narcotic Drugs 
(CND)
Venue: Vienna, Austria 
www.unodc.org
Information: The CND is the central policy-
making body within the United Nations system 
dealing with drug-related matters. It analyses the 
world drug situation and develops proposals to 
strengthen the international drug control system to 
combat the world drug problem.
15–16 March 2007 
2007 National Drug Treatment Conference
Venue: Novotel London West – Hotel and 
Convention Centre 
Organised by/Contact: Exchangesupplies  
Tel: +44 (0)1305 262244 
www.exchangesupplies.org 
Information: The National Drug Treatment 
Conference is an essential event for policy makers, 
commissioners, drug treatment workers and other 
health and social care professionals working with 
drug users. Four major themes will be addressed by 
the conference:
Social exclusion, poverty and drugs
Detox and aftercare
Legal and political issues for drug treatment
New treatments
■
■
■
■
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Improving health through research and information
22–23 March 2007 
First Annual Conference of the International 
Society for the Study of Drug Policy
Venue: P-Hotels Oslo, Grensen 19, NO-0159 Oslo, 
Norway 
Registration: Online, by 16 February 2007 
www.issdp.org
Information: The conference is being supported by 
the Nordic Council for Alcohol and Drug Research 
(NAD) with the Norwegian Institute for Alcohol and 
Drug Research (SIRUS) as local host. Participants are 
invited from a variety of disciplines and institutional 
backgrounds: universities, national and international 
agencies active in drug policy and independent 
research institutions. Practitioners who consider 
themselves consumers rather than producers of 
policy-relevant research will be particularly welcome. 
Four themes will be given particular emphasis: 
developing harm indexes for policy decision; 
estimating government expenditure on drug 
policy; modelling the effects of specific policies and 
programmes; and assessing the impact of harm 
reduction and substitution treatment initiatives.
May 2007 
13–17 May 2007 
Harm reduction – coming of age
Venue: Warsaw, Poland 
Organised by/Contact: International Harm 
Reduction Association 
Tel: +44 (0)208 123 99 81 
Fax: +48 (0)22 640 82 71 
Email: info@harmreduction2007.org 
Information: This annual international conference is 
a key forum for the dissemination of harm reduction 
ideas and practice, attended by over 1,000 people 
from over 60 countries. It brings together frontline 
workers, researchers, policy makers, members of 
governments, officials from law enforcement, the 
judiciary, criminal justice workers, UN officials, 
members of national and international NGO’s, 
together with members of drug user organisations.
June 2007 
10–15 June 2007 
International Council on Alcohol and Addictions 
100th Birthday and 50th Annual Conference 
Venue: Stockholm Conference Centre 
www.icaaconference.se/
July 2007 
7–12 July 2007 
30th Annual Scientific Meeting of the Research 
Society on Alcoholism
Venue: Hyatt Regency, Chicago, USA 
Organised by/Contact: Research Society on 
Alcoholism. Debra SHARP 
Research Society on Alcoholism, Suite D-89, 7801 
North Lamar Blvd.  
Austin, TX 78752-1038 USA 
Tel: +1(512) 454 0022 
Fax: +1(512) 454 0812 
DebbyRSA@sbcglobal.net 
Information: The primary goal of the meeting is 
to provide a forum for alcohol researchers, from all 
disciplines, to present the latest findings and to learn 
about new research developments. 
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Drugnet Ireland mailing list 
If you wish to have your name included on the 
mailing list for future issues of Drugnet Ireland, 
please send your contact details to: 
Drug Misuse Research Division, Health 
Research Board, Knockmaun House, 42–47 
Lower Mount Street, Dublin 2. Tel: 01 676 1176 
ext 127; Email: dmrd@hrb.ie
Please indicate whether you would also like 
to be included on the mailing list for Drugnet 
Europe.
The Drug Misuse Research Division (DMRD) 
of the Health Research Board is a multi-
disciplinary team of researchers and 
information specialists who provide objective, 
reliable and comparable information on 
the drug situation, its consequences and 
responses in Ireland. The DMRD maintains 
two national drug-related surveillance 
systems and is the national focal point for the 
European Monitoring Centre for Drugs and 
Drug Addiction. The division also manages 
the National Documentation Centre on 
Drug Use. The DMRD disseminates research 
findings, information and news through its 
quarterly newsletter, Drugnet Ireland, and other 
publications. Through its activities, the DMRD 
aims to inform policy and practice in relation 
to drug use.
